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SOMMAJRE
Les récidives sont communes après le traitement endovasculaire des anévrismes intra
crâniens. Une meilleure compréhension des mécanismes cellulaires et moléculaires de la
trombose nitra-anévrismale après traitement pourrait conduire à de meilleures stratégies
pour réduire les récidives.
La première étude traite des effets de l’utilisation d’endoproffièse (ou stent) et de la
dénudation endothéliale sur l’évolution des anévrismes et l’occlusion des vaisseaux
adjacents. Des anévrismes expérimentaux ont été créés et traités uniquement par
cstenmig ou par ‘stenting’ avec ou sans dénudation endothéliale. Les résultats
angiographiques et pathologiques des deux groupes ont été comparés. Le ‘stenting’ seul
était insuffisant pour obtenir l’occlusion complète d’un anévrisme, mais les résultats se
sont améliorés lorsque l’endoprothèse etait combinée avec la dénudadon endothéliale.
La deuxième étude porte sur les effets de l’endoproffièse sur l’expression génique des
cellules de la paroi de l’anévrisme et s’efforce d’établir une corrélation entre les
changements d’expression et les résultats angiographiques et pathologiques. Le profil
d’expression de 14 gènes d’intérêt potentiel a été analysé par la RT-PCR sur les tissus du
collet des anévrismes bilatéraux de la carotide, dont l’un d’eux a été traité par un
endoprothèse.
L’utilisation de l’endoproffièse à amélioré les resultats angiographiques. Les profils
d’expression mRNA étaient bien en rapport avec les effets attendus sur la formation
néointirnale et l’organisation du thrombus et avec la recanalisation (ou formation d’un
canal endoffiélialisé à l’intérieur du tbrombus); mais les différences entre les groupes
soumis au ‘stenting’ et les groupes contrôles n’ont pas atteint le seuil de signification
statistique.
Mots-clés anévrisme, endoprothèse (stent), endothélium, gène, modèle animal.
VSUMMARY
Recurrences are common afrer endovascular treatment of intracranial aneurysms. An
understanding of the cellular and molecular biology of intra-aneurysmal thrombus
evolution followmg treatment promises to lead to better strategies to reduce recurrences.
The first paper studies die effects of stenting and endothelial denudaflon on aneurysm and
brandi vessel occlusion. Experimental aneurysms were created and treated with stenting
alone or stenting and endothelial denudation. Angiographic and paffiologic findings were
compared between die two groups.
We found that stenting alone was insufficient to lead to complete aneurysm occlusion, but
resuits improved when stenting was combined with endoffielial denudation.
The second paper studies the effects of stenting on die genetic expression of ceils of die
aneurysm wafl and attempts to correlate changes in expression with angiographic and
pathologic ffiidings. Bilateral carotid aneurysms were created; one was stented. Tissue
from die aneurysm neck underwent RT-PCR at various times to create mRNA expression
proffles for 14 potentially interesting genes.
Stenting led to angiographic improvement of aneurysm appearance. mRNA expression
proffles were in keeping widi expected effects on neointima fonnation and thrombus
organ2aton and with endothehali2ed channel formation within die thrombus, but
differences between stented and control groups did not reach significance.
Key words: aneurysm, stent, endothelium, gene, animal model
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1. INTRODUCTION
This thesis comprises six chapters. The rst provides relevant background regarding
intracranial aneurysms and how they can be treated, followed by an introduction to the
cellular and molecular factors hkely involved in intracranial aneurysm healing. The second
chapter explains the rationale, hypotheses, and goals of die experiments performed for
this thesis, while the third chapter covers the materials and methodology used in
completing and analyzing die experiments. The fourdi chapter is made up of the two
manuscripts produced as a result of tins work. A general discussion of die material within
die papers is covered in chapter five, with some concluding remarks. The sixth chapter
provides references to die literature cited in this thesis.
J .1 INTRACRANIAL ANEURYSMS
1.1.1 Demographics
An aneurysm is an abnormal swelling along a hlood vessel[1J. The reported prevalence of
unmptured aneurysms ranges from O.1-6%, but is likely considerably less than 5% [1].
Aneurysm rupture is die most common cause of spontaneous subarachnoid hemorrhage
(SAH)[2], widi an incidence estimated at 10/100 000 population per year[3, 4J. This
devastating disease strikes women 1.6 times more dian men [1], usually between die age of
30 and 70 years, with a peak incidence during die 6 decade[5]. The consequences of
SAH can be grave, widi approximately 45% overail mortality and moderate to severe
disabffity in 30%[6-$]. In aduks, 85% of aneurysms are found in die antetior circulation,
and most of diese aneurysms are saccular[2]. Postenor circulation aneurysms comprise
l5%, a greater proportion ofwhich are fusiform.
2Aneurysms are much less common in children. Childhood aneurysms often bear atypical
eflologic or morphologic features, and are suspected to represent a distinct padiological
enflty[91.
1.1.2 Etiopathogenesis
The etiopathogenesis of most saccular aneurysms remains unknown. Cerebral blood
vessels normally contain an outer adventifial layer, a middle layer of smooth muscle or
media, an internai elastic lamina, and an innermost intimai layer. Cerebral vessels lack an
extemal elastic lamina, which may predispose diem to aneurysmal formation.
Microscopically, aneurysms are found to have structural changes in die wall of die blood
vessel, including mural atrophy, loss of die internai elastic lamina and media, and thinning
ofthe adventida[lO].
Aneurysm etiologies are commonly classified into acquired or congenital causes. Support
for die hypodiesis that aneurysms are acquired lesions anses from die observation diat
most cerebral aneurysms arise at brandi points or where arteties abmptly change
curvature, implicating chronic hemodynamic stress as a etiologic agent [9J. In keeping
widi this ffieory, die nsk factors most commonly linked to aneurysm formation and
rupture are cigarette smoking and artetial hypertension[1, 11J. Furthermore, intracranial
aneurysms are rareÏy found in children, and are found widi increasing incidence until die
$ decade oflife[11j.
However, diere is supporting evidence for congenital predispositions to aneurysm
development. Several hentable disorders are associated widi intracranial aneurysms,
including Eliers-Daiilos type W, Marfan’s syndrome, neurofibromatosis type I, and
autosomal dominant polycystic kidney disease (ADPKD)[l]. Aldiough a mutation at a
pafficular gene locus has flot been discovered, intracranial aneurysms are known to run
along familial lines[1 1]. Taken together, die evidence suggests diat die causes of aneurysm
formation and rupture are multiple and multifactorial, most likely resulting from a
3combination of genetic factors which predispose the arterial wall to form paffiological
dilations in response to noxious environmental factors.
The remaining causes of aneurysm formation represent only a small minority of cases.
Mycotic aneurysms are those that occur following infection, usually in association wiffi
bacterial endocarditis[2], while post-traumanc aneurysms are an uncommon sequelae of
trauma, usually following a penetrating injury to the arterial vessel wall[2j.
1.1.3 CLïnicat Manifestations
Unruptured aneurysms usually remain asymptomatic, alffiough they may present with
signs and symptoms of mass effect, cortical or meningeal irritation, or occasionally with
ischemic events from emboli originating from witbin the aneurysm. The majonty of
aneurysms are diagnosed afrer rupture, which usuaily causes SAH, intracerebral
hemorrhage (ICH) or subdural hematoma. The annual incidence of SAR in patients with
unruptured aneurysms is stiil unknown, and is the topic of much ciment debate[12-14].
For mptured aneurysms, clinical symptomatology depends on aneurysm siae, location,
bleeding sevetity, and the presence of associated hydrocephalus. Aneurysm rupture can
resuit in sudden deaffi (as high as 65¾ of patients, as reported in die prospective arm of
ISUJA)[12], while the remainder typically seek medical attention for a specirum of
neurological signs and symptoms ranging from sudden headache to decreased level of
consciousness[l, 2]. Typical clinical features include the sudden onset of severe headache,
often with neurological deficits, associated nuchal pain and ngidity, a low-grade fever, and
retmal hemorrhages. Figure 1.1 presents typical CT ndings ofaneurysmal SAH.
FIGURE 1.1
CT head showing diffuse subarachnoid hemorrhage.
Subsequent digital subtraction angiography revealed a lefr
antenor choroidal artery aneurysm.
41.1.4 Complications of aneurysm rupture
3O5O% of aneurysm ruptures are fatal prior to medical or surgical intervenfion[11. In ffie
absence of prompt aneurysm obliteration, approxiruately haif of patients with aneurysm
rupture will die within one month, usually due to re-hemorrhage[1J. For untreated
patients who survive 6 mondis, ffiere is a 2°/o rupture rate per year for ten years, which
fails to 1% after a decade[1]. Rebleeding has an associated mortality of 80%[l1. Mortality
for patients who survive unifi treatment is approximately lO%, with 60% of survivors
having a favorable outcome[5]. Overail mortality from SAH ïs approximately 60-65%[12,
15]. Offier potentially life-threatening early complications include acute hydrocephalus
due to blockage of cerebrospinal flmd flow by thrombus formation within the ventricular
system or basal cistems[2]. Vasospasm of major mtracranial vessels secondary to dot and
dot breakdown products in the subarachnoid space can lead to cerebral ischemia or
infarction. Offier potential complications of aneurysm rupture incÏude neurological
deficits, treatment-related complications, systemic complications secondary to acute
physiological stress, as well as complications secondary to irumobility. Chromc
hydrocephalus is a common sequel of aneurysmal SAH, often requinng shunting of
cerebrospinal fluid.
1.2 TREATMENT 0F INTRACRANIAL ANEURYSMS
Wbile the treatment of unruptured aneurysms, without more complete knowledge of the
natural history, remains a malter of debate, there is litde controversy that mptured
aneurysms should be treated to prevent further rebleeding. In general there are two
options for the treatment of intracranial aneurysms; open suxgical or endovascular
treatinent.
51.2.1 Open surgicaL treatment
Current surgical treatment 0f saccular aneurysms typically consists of a craniotomy to
place a meta]lic clip across ffie base of the aneurysm, effectively removing the aneurysm
from the circulation and maintaining or recreating a normal arterial configuration (Figure
1.2). The aneurysm clip re-apposes the arterial mural structures between the clip blades,
maintaining a continuous endothe]ial covering layer.
Figure 1.2
Aneurysm clip across the neck of a
sidewail berry aneurysm, removing it from
the circulation. (From Boston Sdentiflc;
www.bostonscieniific.com)
Surgical rates of morbidity and mortality for unruptured aneurysms are typically reported
in surgical case senes to be <4% and <2%, respectively[16-1$], a likely underestirnate
related to publication bias. However, the ISUJA investigators have repeatedly reported
surgical morbidity and mortality rates for unniptured aneurysms ranging from 12.6-
I 5.7%[l2, 19]. For rnptured aneurysms, in cases deemed salvageable, surgical mortality
rates range from 7-29%[1 j. Morbidity due to surgery on mptured aneurysms is difficuit to
separate from morbidity due to the aneurysm rupture itselE
Other surgical trealments for uncippable aneurysms depend on die nature, morphology,
and location of the aneurysm, as well as die surgical exposure. Aneurysmorrhaphy with
parent vessel reconstruction or surgical bypass following by parent vessel occlusion offer
deffiiltive treatment, but are more technically difficuit and carry more nsk[20j. Other
alternatives, such as aneurysm wrapping with muscle or mushn gauze to reinforce the wall,
are of dubious efficacy, being used only when there are no offier options[20j. As the role
of endovascular therapy is increasingly recognized, partial neck cipping followed by
coiling is recognized as a viable alternative for difficult cases [20].
61.2.2 Endovascutar treatment
Endovascular treatment, an mcreasingly popular alternative to surgery, involves arterial
puncture at a remote site, with navigation to and deposïtion of vatious matedals within the
circulation. The tise in popularity was inifially due to the less invasive nature of
endovascular treatment, which is now supported by the publication of the multicenter
randomiaed ISAT trial of ruptured aneurysms, winch showed decreased morbidity and
mortality at 1 year for endovascular treatrnent (23.7%) compared to surgery (3O.6%)[21].
In general, endovascular treatment strategies can be directed towards either the aneurysm
or the parent vessel (Figure 1.3). When the strategy targets the aneurysm, thrombogenic
material (typically platinum coils) are deposited within the aneurysm fundus, in hopes of
causing a locakzed reaction wiffi tbrombus formation, followed by dot organization and
neointimal formation to obliterate the aneurysm and restore normal blood flow pattems.
The strategy of coil deposiflon within aneurysms was shown wiffi ISAT to be of clinical
benefit.
Treatment directed towards the parent artery can be eiffier ‘deconstructive’, occluding the
parent vessel as well as the aneurysm, or ‘reconstructive’, using stents to alter aneurysm
hemodynamics, provoke thrombosis and promote neointima formation at the junction of
the parent vessel and aneurysm neck. Strategies to treat aneurysms using stents have
neyer been proven beneficial but are increasing in populatity[22J. I will start by
introducing the well-accepted embolization procedure and review the limitations of tins
strategy. I will then discuss the potential benefits of stents as adjuncts to coil
embolization, or as a prirnary mode of treadng intracranial aneurysms.
7Artist’s rendition of different endovascular strategies to treat aneurysms
A) Coils deposited within the aneurysm. B) Endoluminal stent deposited in the parent
artery to bridge the neck of the aneurysm. (from Boston Scientific;
www.bostonscientific.com)
1.2.2.1 Colts
Although emboli2afion of aneurysms wiffi vanous materials, including free coils, baRbons,
and glue had been possible for decades for rare lesions, its clinical use remained
exceptional unifi the introduction of Gugliehni detachable coils (GDCs) in 1991. Bnefly,
endovascular treatment wiffi GDCs involves packing multiple thrombogenic platinum
coils into an aneurysm to prevent blood from entering the fundus. The coils adjust to the
contours of the aneurysm, and once sadsfactorily posirioned, the operator separates the
coil from the stainless steel delivery wire through an electrolytic process. The key feature
of GDCs was this detachment system, winch permitted the retrieval and reposifiornng of
the coils when necessary, with detachment only when the coils were safely and stably
positioned within the aneurysm. The improved safety proffle imparted by the detachment
system led to the increased popularity of endovascular treatment, with littie concem for its
long-term efflcacy. Afthough coiEng can lead to good outcomes, there are several
important drawbacks with tins technique. One occasionally encountered limitation of
Figure 1.3
8endovascular therapy is difflcuk intravascular access due to atherosclerosis, which
prevents proper negofiation of wires and caffieters to access the aneurysm. This difflculty
is exacerbated when the aneurysm is located in tormous or distal vasculature.
Complications at the arterial puncture site in the groin can also lead to chnically significant
hemorrhages, occasionally requiring penpheral vessel stent-grafring. However, the most
important drawback associated with endovascular coiling remains the angiographic
recurrence rate, winch is reported to approach 2O4O%[23]. In a most recent case seties
die retreatment rate following endovascular coiling reached 15% after two years, but the
clinical significance of these recurrences in ternis of rehemorrhage was very modest [24].
Although the tisk of rupture of aneurysm recurrences is stiil not lmown, die fear of SIkH
from an aneurysm recurrence continues to lead some neurosurgeons to treat aneurysms
with surgical cipping. Attempts to decrease recurrence rates have focused mostly on coil
modification; coatings to promote thrombosis [25], to increase aneurysm packing
density[26j, emit radiation[27], or biologicailv active coatings[2$J have been introduced,
but none have successfuily decreased recunence rates. Uquid embolic agents such as
Onyx have also proven ineffecflve in tins regard[29]. Finaily, endovascular techniques are
flot suitable for ail aneurysm morphologies; coils deposited witbin aneurysms with wide
necks or a dome:neck ratio of <2 are at nsk of hermating into the parent vessel, leading to
thrombo-embolic complications. Technical innovations, such as the balloon-remodeling
technique have been developed to address tins, but tins adds complexity and procedural
tisk[30]. The notion to use stents in die intracranial circulation originated from die need
to prevent coil herniation in wide-necked aneurvsms.
1.2.2.2 Stents
Stents are made of tubular metaffic mesh, and were originaily designed to treat acute or
subacute coronary artery occlusion following bailoon angioplasty, aiming to prevent recoil
of die arterial wail after balloon dilatation. Balloon-expandable stents were introduced
into atherosclerotic vessel segments and die balloon forcibly expanded to dilate die lesion,
leaving die stent in situ in order to maintain vesse1 patency. Neuroendovascular therapists
9have benefited from the cardiology experience regarding ischemic complications and
vessel re-stenosis from neointimal hyperpiasia following stenting, but die cardiology
literature is not aiways applicable to intracranial disease processes. Important pathological
differences between diseased atherosclerotic blood vessels and vessels bearing aneurysms
may alter the artetial response to stenting.
The use of stents for intracranial applications lias been hampered by die accessibility ta
die tortuous intracranial circulation. Initial stenting attempts for intracranial pathologies
used coronary stents as an ‘off-label’ indicaflon[31]. The balloon-expandable coronary
stents are designed ta exert large radial forces ta force open atherosclerotic stenoses and
then maintain vessel patency. The coronary stents available on die market were quite
rigid, and neuroendovascular therapists found diem difficuit ta navigate through die
carotid siphon at die skufl base[32]. Balloon-expanclable stents are limited by their poor
flexibffity and ‘pushabffity’, as compared ta seif-expandable stents[33]. Nonedieless, in die
less tortuous postetior circulation, balloon-expandable coronary stents have been
successfully used ta treat aneurysms [34]. More recently, self-expandable stents designed
specffically for intracranial applications have been developed. These devices and dieir
deployment systems are more flexible, enabling intracranial navigation. In contrast ta
dieir coronary counterparts, intracranial stents do flot need ta open stenotic segments, and
self-expandable stents, winch exert smaller radial forces but adapt more closely ta die
contours of die parent vessel, are more commonly used dian balloon-expandable stents.
Self-expandable stents must nonedieless exert sufficient radial force ta praperly anchar
die stent within die vessel, ta prevent stent migration, or ta prevent die hemiation of coils
out of aneurysms[30].
In die treatment of intracranial aneurysms, stents are typically used in canjunction widi
coils or odier embolic agents, aldiough diey can be used alone (Figure 1.4). As previously
mentioned, die main utility of die stent in conjunction widi endovascular treatments is ta
prevent die herniation of embolic material into die parent vessel, especially for wide neck
or fusiform aneurysms [35, 36]. However, die use of stents for routine non-wide necked
aneurysms has been suggested, due ta dieoretical effects of die stent on aneurysm healing.
Stents are diought to act primarily by redirecting blood flow along die parent vessel,
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altering aneurysmal hemodynamics and promoting thrombosis [37, 38]. Redirecting blood
flow forces may also promote more complete aneurysm healing and decrease recurrence
rates by re-establishing a new endoluminal boundary that exciudes the aneurysm. The
stent may also buffer the hemodynamic forces implicated in recunence, or alter die fluid
dynamics in die area of die stent, thereby promoting neointima formation [39]. The
effectiveness of the stent at achieving these goals depends primarily on the stent design.
Figure 1.4
Artist’s rendiflon of endovascular coiling
in conjunction widi stenfing. Note how
die stent prevents coil herniadon into
the parent vessel lumen.
The choice of stent should be based on die site and morphology of die aneurysm, the
stent design, as well as die delivery system. The relevant morphology of the
aneurysm/parent artery complex includes die caliber of die parent vessel, the desired
length of “landing zone” for die stent, die widffi of die aneurysm neck, and die presence
of branch or perforator vessels[30]. Stents are usually chosen to match die caliber of the
recipient vessel[401. Intendonal attempts to over-dilate cerebral vessels has led to
extremely high morbidity and mortality rates[41]. Manufacturers recommend a “landing
zone” of 4-5 mm on eidier side of die aneurysm neck[32]. Longer stents present a larger
thrombogenic surface area, and carry a greater theoretical tisk to branch or perforating
vessels. M sites of tight vessel curvatures, a more flexible stent is required to conform to
die parent artery.
The design of die stent includes die sire, composition, and structure, including the
number of struts per circumference. Clinicians can choose from a vatiety of lengths and
diameters, but most stents in current clinical use are made of nitinol, a nickel-titanium
afloy. The ideal stent composition is one that renders die stent biologically inert and non-
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thrombogenic, and nitinol has been shown to be superior to odier metals with respect to
neointimal hyperpiasia and in-stent stenosis[42]. for nitinoÏ stents, radio-opaque markers
must be added to guide proper deployment, because nitinol is radiolucent.
A properly chosen stent structure is paramount to avoid complications[43]. Stent strut
widdi and ceil size dictate die porosity of die stent, which is die ability for blood to
continue to flow outside die confines of die stent mesh (ie: into die aneurysm or adjacent
branch vessels) [30]. The ideal stent porosity alters blood flow sufflciently to provoke a
localized tbxombosis within die aneurysm wbile sparing ail small vessels originating from
under die stent[30]. These opposing goals may flot always be attainable with die stents
currenily available, and compromise is often necessary. In cases devoid of critical
perforators, where thrombosis is desired anywhere outside die confines of die stent, die
ideal stent would be a stent covered with an impermeable membrane widi a non
dirombogenic internai surface. Covered stents such as diese are usefiil to treat fusiform
aneurysms widi no perforators arising from die parent vessel[441, and are also used to
treat abdominal aortic aneurysms [45]. Stents widi a greater number of struts Qower
porosity) are able to exert a greater amount of radial force. Radial force is an important
consideration in adierosclerotic disease, where die main goal of die stent is to maintain
vessel diameter, but for intracranial aneurysms, a minimum of radial force is required to
prevent coil herniataon or stent migration. The number of struts correlates widi die
amount of potentially thrombogenic surface area, and may pose a greater risk of parent
vessel thrombosis. The number and type of hnkages between stent ceils furdier dictates
die flexibiilty of die stent. These consideraflons have led stent manufacturers to create
higliy flexible, high porosity stents widi few stent struts per cross-secflonal diameter.
The stent deployment system is also of crucial importance to a successftil endovascular
procedure. The two most important features are navigabffity and mediod of delivery (self
or bailoon-expandable). Stents designed for intracranial use are now sufflciendy navigable
to access most aneurysms of die posterior and anterior circulation. Self-expandable stents
offer several advantages compared to bailoon-expandable stents. These stents are
deployed by puDing back die sheadi covering die spring-loaded stent, winch expands to
fUI die contours of die parent vessel. The low radial force exerted by a seif-expandable
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stent is sufficient to anchor the stent witbin tEe lumen, as well as to prevent coil herniation
into tEe parent vessel in most cases if necessary. This meffiod of delivery does flot cause
angioplasty-type injuries when deployed, wbich may reduce the incidence of neomtimal
hyperpiasia and in-stent stenosis[46]. Bailoon-expandable stents are designed to expand to
a frced volume, and are more prone to migration within tEe parent vessel if ffiey are
undersized.
The tisks of stenting can be classified as acute or chromc. Thrombogenic nsks comprise
tEe majoiity of acute and subacute tisks due to stenting[32]. The tbrombogenicity of
intracranial stents is almost indisputable given the cardiology expetience with coronary
stents[47], and as ail stenting procedures are now performed using vigorous anti-platelet
regimens, it is ethically impossible to determine tEe nsk of tbrombosis due to stents by
tEemselves. The best anti-platelet regimen bas flot been decided upon, but several have
been suggested for intracranial stents under various circumstances [32, 35, 48]. Stent
deployment also carties ischemic nsks to perforating vessels, by pardaily occluding vessel
ostia originating under the stent, or causing embolization of fragments of atheroma [49].
It is important to note the difference in thrombotic tisks between die conventional coiling
strategies that target aneurysms by depositing coils outside die normal circulation and
stenting strategies that deploy devices within die parent vessel. The vessel trauma caused
by die stent and the permanent deployment of a foreign body creates a risk of thrombosis
to die exact vessel we aim to preserve. Thrombotic complications can also occur in a
delayed fashion, requiring long-term anti-platelet ffierapy. The use of these agents afrer
SAH may be a source of additional hemorrbagic complications, including aneurysm
rebleeding, or foilowing odier procedures, such as extemal ventricular drainage. Odier
risks of stenting include suboptimal placement, migration, fracture, or prolapse into the
potential spaces outside the vessel lumen, such as a branch ostium or aneurysm [33, 50].
Catastrophic artetial perforation may also occur[33J. finaily, die artetial response to
stenting can also lead to neointimal hyperpiasia and in-stent stenosis, winch is weil
characteiized in the cardiology literature. Although the nature of die aneurysmal disease
process differs from die atherosclerotic coronary situation, intracranial in-stent stenosis
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due to exuberant neointima deposition with hemodynamically significant flow reduction
has been reported[51].
1.2.3 Aneurysm recurrences foltowing treatment
Following complete surgical cipping as determined on angiography, aneurysm recurrence
rates range from 1.5 to 3%[52]. for surgically cipped lesions with known residua, die
recurrence rate is 7-25%[52, 53]. Endovascular treatment is eidier incomplete or is
associated with aneurysm recurrence in 2O4O% of cases [23]. Engineering and biomedical
strategies to decrease recurrence rates through novel device designs and biological coil
modifications have not solved die problem of recunences. Most developments were
proposed by manufacturers and developed by engineers, with littie concems for the
biological mechanisms involved in healing or recunences following endovascular
freatment. There is a need for better characterization of die molecukr mechanisms
occurring followmg aneurysm treatment to help engender and guide further attempts to
decrease recurrence rates.
1.3 MECHANICAL AND HEMODYNAMIC FORCES ACTING ON
ANEURYSMS
1.3.1 Overview
Blood flow is a resuli of repetitive coordinated myocardial contractions which propel
blood through the vascular tree. In vivo hemodynamic forces are complex; they vary with
cardiac cycle, heart rate, blood pressure, blood viscosity, vessel architecture, and
viscoelastic properties of die artery[54]. Forces generated by pulsaffle blood flow are
attenuated pdmarily by two processes: elastic stretching of die arterial media, and friction
between die elements of blood and die vessel wall. Chonic padiological elevation of
diese forces has been implicated in die formation and rupture of intracranial aneurysms [1].
The nature and magnitude of hemodynamic force acting on an aneurysm depend on die
location and morphology of die aneurysm. Following endovascular treatment, die
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orgamzing thrombus is subjected to continued pulsatile blood flow, which potenlially
impacts many of the ongoing biological processes.
Mechanotransducflon was initially thought to be due to activation of specific
mechanoreceptors, such as a mechano-sensifive ion channels or ceil surface adhesion
molecules, but there is also evidence for die entire endodielial ceil cytoskeleton to act as a
mechanoreceptor [55, 56]. Eukaryotic ceils are able to maintain cytoskeletal rigidity
through cytosolic ifiaments diat generate and resist mechanical loads [55, 57]. These
intracellul2r scaffolds aliow the ceil to respond to mechamcal signais from the
environment, by transducing cellular deformations through cellular signaling padiways,
resulting in physiologic or paffiologic responses[58]. Forces of lesser magnitude that
would flot normally deform die ceil soma are able to trigger mechanotransduction
signaling paffiways through the deformation of ceil surface receptors, such as integrins[59,
60]. The establishment of appropriate ceil-ceil and ceil-matrix contacts is cnflcal for
transduction of mechanical forces in smooth musde flssue[61]. Here, I will discuss die
hemodynamics of lateral wall aneurysms, followed by a description of die two types of
mechanical forces acting on vascular ceils.
1.3.2 Aneurysm hemodynamics
Aneurysm hemodynamics studies reveal diat flow within an aneurysm depends primarily
on the morphology of the aneurysm and the relationship to the parent artery[62]. For
lateral wall aneurysms, three distinct zones have been descnbed: f) an inflow zone
entenng die aneurysm at die distal portion of die ostium, 2) an outflow zone exiting die
aneurysm at die proximal end of die ostium, and 3) a centrai slow flow vortex [63].
Modification of die inflow zone may provoke aneurysm thrombosis while maintaining
parent vessel patency [63]. The abffity of stents to modify die infiow zones of an
aneurysm are well documented[62], and this effect of stents hkely contributes to die
obliteration of literai wall aneurysms (Figure 1.5) [42].
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FIGURE 1.5 Schematic comparing flow dynamics of non-stented versus stented
aneurysms
Hemodynamic forces have long been implicated in ffie initiation of atherosclerosis, wiffi
greater levels of laminar flow conferring an atheroprotective phenotype[64]. There is an
increased incidence of atheroma formation on the proximal portion of diseased branch
vessels, purportedly due to decreased laminar shear stress or increased [641. Shear stress
is lmown to modulate gene expression (see section 1.3.3.2) , and the loss of a protective
genetic expression proffle may trigger cellular and molecular events that account for
affieroma formation localized to vessel bifurcations [65].
Blood flow into a lateral wall aneurysm concepmally resembles that into a brandi vessel;
the distal portion of the ostium acts as a flow divider, and is exposed to higher levels of
shear stress compared to the proximal aneurysm ostium [66]. The observed increased
neointima formation at the proximal ostium [67] hkely reffects this difference in laminar
shear stress between proximal and distal ostia.
1.3.3 Mechanical forces acting on vascutar cetts
Stretch and shear stresses are important physiologic stimuli known to ttigger ceil signaling
in vascular cells[56, 68, 69]. Although endoffielial ceils (ECs) and vascular smooffi muscle
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ceils (VSMCs) are exposed to both types of mecharncal force, die sheax stress from blood
flow is borne primarily by ECs, while VSMCs are primarily subjected to cycic stretch
from pulsatile pressure[69]. The response to mechanical forces may be important to the
occurrence of aneurysm recurrences following endovascular treamient.
1.3.3.1 Cyctic WaLt Stress
Cydic wall stress is the tensile stress vector acting perpendicular to the blood vessel lumen
diat occurs as die blood vessel lumen is expanded widi systole[70]. This force, which
primarily affects vascular smooth muscle ceils, resuks in 5-6% wall excursion at peak
systole under normal physiological conditions, and can be as high as lO% under
hypertensive condiflons[71]. Mechanical stretching of cultured VSMCs lias several effects,
including reonentation of ceils, changing protein and DNA syndiesis, and increased
production of extracellular matrix components [61]. Mechanical stretch also promotes
stem ceils to differentiate into VSMCs, and may also lead to transdifferentiation of ECs
into VSMCs[70j. Chronically elevated cydic wall stress is a feature of hypertension, which
induces VSMC hypertrophy and hyperplasia [72]. Meclianical strain also leads to
increased production of proteoglycans[73], and promotes extracellular matrix
remodeling[70]. This cellular response aims to counterbalance die applied force by
forming more extracellular matrix to buttress die vessel wall. Stent placement likely
decreases die net cycic strain sensed by die artetial wall by absorbing some of die radially
directed force of pulsaffle blood.
1.3.3.2 Shear Stress
Shear stress is die frictional force exerted at die endodielial apices caused by die flowing
elements of die blood. The velocïty of flowing blood is maximal in die center of die
vessel lumen, and decreases as it approaches die wall[74j. The fluid can be viewed as
divided into a seties of adjacent layers moving at different velocities wiffi respect to each
other. The velocity differential creates die shearing flow. Blood flow is disturbed at
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branch points and curved areas of the vascular tree, compared to die simple laminar flow
in straight parts of die aorta[69j. The endodielium acts as a sensing surface to transduce
shear stress forces, using surface integrins, intercellular adhesion molecules, \ŒGFR-2,
ion channels, G-protein coupled receptors, and ftimeric G proteins[69]. Endothelial ceils
change dieir genetic expression profiles with the different types of shear forces, i.e.:
laminar, disturbed, or oscfflatory flow[69]. Laminar flow resuits in die upregulation of anti
proliferative, anti-in&mmatory, and differentiative properfies, widi down-regulation of
genes associated widi ceil cycle progression and proliferation[69], which is of particular
importance to adierosclerosis and localized neointima formation.
Abrupt reductions in fluid shear stress has been shown to induce VSMC proliferation in
expedmental prosdietic grafts[75J. Stenting likely dismpts the laminar shear of blood
entering die aneurysm, leading to turbulent blood flow. We hypothesize diat die stent
related disruption in blood flow will resuit in a change in genetic expression at die level of
ceils of die aneurysm wall, wbich we hope to correlate wiffi angiographic and paffiologic
indicators of aneurysm healing.
1.4 ENDOVASCULAR TREATMENT RESPONSE
1.4.1 Overview
The primary goal of therapy is to protect patients from rupture or re-rupture; because of
historical evidence wiffi surgical cipping and balloon embolizaflon, it is generally diought
that stable, long-term angiographic exclusion of die aneurysm is die sunogate endpoint to
aim for. To conflrm tins hypothesis, observational study of ffiousands of patients for
many years would be necessary to determine dlinical efficacy, something winch is
incompatible wiffi die steady technical and clinical advances in tins field. An alternative
hypodiesis, from paffiological studies in animal models, suggests diat a thick, complete
neointima is die signature of a stable occlusion. Furdier refinements suggest that a thick
neointima completely closing die neck of die aneurysm is die resuk of normalized flow
pattems, widi die mtra-aneurysmal thrombus fully organi2ed, widiout recanalization.
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Endovascular therapy relies on the vascular biological response to lead to a successfiil
outcome. Short terni goals of dierapy include occlusion of the aneurysm. While some
mediods can achieve this by purely mechamcal means (surgical dipping, onyx glue or
balloon embolization), endovascular treatment usually relies on thrombus to achieve tins
goal. Subsequent evolution of die formed intravascular thrombus is crucial to the long
term outcome of aneurysm treamient, wbich is dependent on the dominance of one of
two phenomena: a) organization of the thrombus and neoindrna formation at the neck
and b) recanalization [76]. The most important long-term outcome is protection from
aneurysm rupture, but it is unknown what deg-ree of protection, if any, is conferred by
partial aneurysm occlusion. Given die paucity of natural history data regarding
angiographic recurrences, an ideal resuit would also produce stable, non-threatening
angiographic resuits. The anticipated pathological correlates of this angiog-raphic endpoint
would require die formation of a new, stable mural structure completely occluding die
aneurysm, and covered by a continuous sheet of endothelium.
The molecular response to endovascular dierapy is a complex and incompletely
understood process diat may be conceived of as a reaction to a fomi of vascular injury.
The universal response to vascular injury involves neointirna formation, as docurnented
after a wide array of physical or chemical injuries to die timer (endothelial) or outer
(adventitial) layers of die vessel wall. The molecular response to vascular injury depends
on die nature and severity of die injury, but generally involves every type of ceil in die
vicinity (vascular smoodi muscle ceils, myofibroblasts, endodielial ceils, platelets and
leukocytes) as well as circulating ceils, elements in die blood, and die extracellular
matdx[56, 77, 78]. Because die response to embolic treatment is a relatively new area of
investigation, many observed phenomena are interpreted in light of mechanisms and
concepts previously evoked in odier more mature research areas, such as re-stenosis
following artetial balloon injury widi or widiout stenting, angiogenesis, affierosclerosis,
thrombosis, organization, inflammation, recanalizanon, and endodielialization. Most
pertinent to this diesis are thrombosis and thrombus organization, and die processes of
neointima formation, re-endodielialization, and recanalization.
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1.4.1.7 Thrombosis and Inflammation
Clotting is a requisite component for circulatory liomeostasis, and is involved in the
recovery of vascular integrity following injury[79]. For inapproptiate intravascular
clotting, such as ffiat triggered by paffiological mechanisms, blood flow may be restored
early, by thrombolysis, or late, through the process of recanali2ation[79]. Endovascular
aneurysm treatment aims to form a thrombus localized witbin the aneurysm; the
thrombotic reacflon to the introduction of an intravascular foreign body, as well as the
tissue reaction to the dot, involves mediators classically considered as part of
inflammation. There is a link between an excessively vigorous inflammatory reaction and
neointima formation, at least in terms of clinical models of in-stent restenosis [801. A
more detailed molecular explanation of die vast subjects of dirombosis and inflammation
are considered beyond die scope of this thesis.
7.4.1.2 Thrombus Organization
Thrombus organi2ation is the process that converts a dirombus into tissue. In a
successflilly organized thrombus, pathologists distinguish two sets of vessels: a) vasa
vasorum of die outer and middle coats of the organized thrombus, and b) vessels diat
form channels within die thrombus[79, $1]. The organi2ation of intravascular dots relies
on several cellular events: i) die portion of the dot exposed to flowing blood is coated by
monocytes, which subsequently penetrate the dot; ii) die flow-exposed surface of die dot
is re-endodiehahzed, in) myoflbroblasts and neo-cap•es appear or develop within the
tissues [79]. Occasionally, the neo-capfflaries destined to provide blood supply to the
newly formed tissue flhling die aneurysm can re-join die parent vessel, contributing to
thrombus recanalization (also see section 1.4.1.5).
In treated experimental aneurysm specimens, the tissue found witbin the aneurysmal sac
continues as a ‘neointima’ at die neck, closing die entrance to die sac, and diere is no clear
demarcadon between die so-called neointimal layer and die organized thrombus.
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1.4.1.3 Neointîma Formation
An integral aspect of aneurysm healing is neointima formation at the neck, representing a
universal response to vascular injury, characteri2ed by the formation of myxoid tissue with
stellate-shaped smooth muscle ceils in a loose extracellular matrix[82j. Tradiflonaily,
neointima formation was thought to occur in three phases: i) an acute phase, characten2ed
by interactions of platelets, thrombin, and leukocytes which release biologicaily active
mediators and activate medial smooth muscle ceils; ti) an intermediate phase, where
smooth muscle ceils divide and migrate to die area of vessel injury; and iii) a chromc
phase, where large amounts of extracellular matrix are produced and subsequendy
undergo a process of remodehng[77]. It is important to note that die classic ‘neointima’
was descnbed in affierosclerosis models devoid of intima, or in endothelial injury models,
leaving ail other panetal layers to participate in the pathophysiological process; die classical
theory emphasized VSMCs migrating from die media to die sub-endothelium[77J, but
others, using large animal models, descnbed die importance of thrombosis, followed by
endothelia]ization, with VSMC inifitrating die thrombus as a key feature in neointima
formation[83-85]. In aneurysms, afrer endovascular treatment, we wish to see ‘neointima’
replacing and closing die space where blood was flowing. Hence, a provisional manix
(dot) is a sine qua non pre-requisite, ami die neointima formed in fact represents
replacement of die dot by a new parietal layer composed of ‘organiaed dot’. The new
parietal layer delimits die space wiffi residual blood flow (as dened by die endoffielium)
from die contents of die occluded aneurysm, which subsequendy lls with connective
tissue. In this perspective, diere is a continuum between dot orgai±ation (within die
occluded sac) and neointima formation (closing die neck of a completely treated
aneurysm).
The classical paradigm of neoinfima formation has been chailenged by die discovery and
implication of circulating blood elements in vascu]ar repair. Circulating ceils, in particular
endothehal progemtor ceils (EPCs), as well as dendiatic ceils, form part of a ever
expanding list of ceils involved in this complex biology[86, 87]. The cellular milieu in
wbich vascular heahng occurs consists of many different ceil types, producing and
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responding to various chemical and mechanical stimuli. Some of ffie regulatory factors
likely involved in tItis process will be discussed in section 1.5.
1.4.1.4 Re-endothetialization
The endothelial Iming regenerates to cover new mural structure fiffing the aneurysm
orifice. Regenerated endothelial ceils on the neoindmal surface may migrate from adjacent
healthy vascular wall, from the adventitial vasa vasoffim, or arrive from the
bloodstream[86, $8]. Following stent implantation in animal models, 20% of
endothelialization occurs by 4 days, <40% at 7 days, while endotheliali2afion is typically
complete by 2$ days[89]. However, the importance of the process and timing of re
endothelialization is a controversial topic[90]. One strategy in the cardiologists’ baffle
against restenosis aims to reduce neointimal hyperpiasia by promotmg early re
endothelialazation using growth factors such as VEGF [89]. Efforts within the
neurovascular arena to diminish ffirombo-embolic complications originating from the
thrombus around the coil mass have also targeted early re-endothehalization as a
therapeutic goal[2$, 91]. However, our laboratory lias shown an association between the
integrity of the endothelial hrting and recunences; early re-endotheliali2ation may counter
balance thrornbus organization and promote the formation of endoffielialized channels
witbin the thrornbus[92, 93].
1.4.1.5 Recanalization
Recanalization is a process that potentially compromises the long-terrn occlusion of
endovascularly treated aneurysms. In general, circulatory horneostasis lias two limes of
defense against intra-vascular thrombosis, winch in most cases is a paffiological
occurrence. Acutely, thrornbolysis occasionally succeeds in opening up occluded vessels.
However, when thrombolysis fails, the more chronic process of recanalization attempts to
create new channels through or beside the dot to rejoin the patent portions of the
vasculature. Much of the evidence for recanalizaflon cornes frorn work done on deep
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venous thrombosis, akhough certain aspects of this process, such as ffie growth of
prog-ressively maturing channels through a matrix share conceptual similaiities with
angiogenesis and artenogenesis. The theoreiical importance of mechanical signaling is
detailed in section 1.3.3.
Bnefly, die restoraflon of blood flow across occluded blood vessels seems to depend
primarily on die activity of two ceil population, monocyte/macrophages (MC/MPh), and
circuladng progenitor cells[79J. MC/MPhs, under the influence of the chemoldne MCP-1,
act to penertate the extracellular matnx formed by die mass of platelets and fibrin, and
create tubular spaces, or ‘tunnels’[94j. Matrix metalloproteinases are further known to be
important to this process[941. These tunnels are subsequently seeded with circulating
progemtor ceils. In turn, diese (at least in some hypoffiesized paradigms) will differentiate
into different types of ceils depending on die depth of penetration. On die surface of die
thrombus, they would differentiate into endothelial ceils, wbile ceils adopt a myoflbroblast
or smooth muscle character in die deeper layers[79, 95]. Uhuînately, die capifiaries formed
in die deeper layers may form communications with the endodielium hned clefrs at the
surface of the thrombus. For pathological thrombi with a blood vessel, this can serve to
re-establish blood flow across occluded vessels; in endovascularly rteated aneurysms, this
potentially leads to recurrences.
1.4.1.6 A more ïntegrated view of aneurysm healing
Because research domains tend to develop along existing concepts, attempts to
understand the mechanisms of aneurysm healing usually follow one of two paradigms.
The rst paradigm relies on similarides between the formation of neointima in models of
artetial restenosis and at die neck of rteated aneurysms, while die second emphasizes die
similarities between angiogenesis and die formation of endoffieliaEzed clefrs in
recunences. We have a tendency to conceive of die biological reaction to die presence of
die endoluminal dot as consisting of two opposing phenomena; one assuring a permanent
occlusion (organi2atton/neoindma formation) and die other promoting re-establishment
of die lumen (recanalization). Boffi mechanisms, however, are in fact synchronous and
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colkborative in restoling lumen patency and blood flow. It would be less efficient to
attempt to remove die entire volume of die dot initially. Recanalization and re
endodielialization of channels permits die rapid re-establishment of some blood fiow.
Inifitration of die dot with myofibroblasts will allow die formation of an interconnected
network of Œ-actin positive ceils and extracellular matrix diat can retract die organizing
dot (Figure 1.6). As obstructing tissues are being ‘contracted’, die endodielialized spaces
correspondingly expand, leading to a vessel lumen of increasing diameter and more
efficient blood fiow. Seen in tins manner, bodi phenomena coninbute to recovery of die
integrity of die vessel. In this integrating perspective, recana]ization leads to blood flow,
and blood fiow promotes recanalization.
Ibrombus invaded
bycxSMAceIlsto
replace provisional matrix
Schematic showing process of recanalization following endovascular treatment, widi
thrombus invasion by Œ-SMA ceils and formation of small endodielialized channels
between thrombus and aneurysm wall. Subsequent dot contraction, widi continued
hemodynamic forces, leads to channel expansion and aneurysm recurrence. (Illustration
by G. Gevry)
One could also note diat endodielializafion, neointima formation, organization, and
recana]izaflon are die names or labels used to focus on one or another aspect of die
vascular healing phenomenon, winch in fact is a more complex and dynamic reaction dian
diese concepts would suggest. These ternis permit us to orient research into aneurysm
FIGURE 1.6
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healing, but ffiey have also been the origin of much confusion and misconception. Better
characterization of the ceils and molecular mechanisms involved in thrombus organizanon
/ neointima formation and recanali2ation promises to provide dues winch can be used to
decrease the rate of aneurysm recurrence. One of the goals of this work was to gain
insight into the establishment of endotheliali%ed channels that we have found to form
within some treated anearysms. For example, by examining the expression proffle of the
endothelial marker CD34 over time, we hoped to gain insight into the ldnetics of
endothelializanon of these channels, winch may represent the precursors to recurrences.
1.4.2 CeIts involved in the response to endovascutar treatment
Traditionally, ceils were identified and cktssffied on the basis of microscopic appearance,
relying on differential stain uptake or typical topograpincal loca]izations to distinguish ceil
types. Advances in molecular diagnostics have added a level of complexity to ceil
typologies, winch now rely on antibody recogrntion of cd surface markers with various
degrees of specificity. The difflculty in exact determination of ceil nature and origin
cornes from the fact that typical, charactenstic, or so-calied ‘specific’ markers can be
descnbed only when ceils occupy their typical location and acquired their destined
function. When anatomy and physiology are disturbed by some event, die transient,
migrating, and proliferating ceil types harbour intermediate phenotypes appropriate to
their momentary functions and can no longer be identified with certainty using these
‘specific’ markers.
Iniiially, die ceils diat form die neointirna were thought to be of smooth muscle ceil origin
because of c-smooth muscle actin staining, but subsequent investigation has led to
uncertainty regarding die nature and otigin of Œ-SMA+ ceils. This has led to the adoption
of multiple paradigms, depending on the paffiobiologic process under snady. For
example, -SMA+ ceils found witbin the neointima have been assigned a medial VSMC
origin in die cardiology restenosis and affierosclerosis literature, while the vascular wound
healing and dot organizaflon literature implicates die advenfltial myofibroblast as the
progenitor of Œ-SMA+ ceils. More recendy, circulating precursor ceils have been
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described, as well as a thesis involving the transformation of monocytes into
myofibroblasts [1•
Simihrly, classical theory taught that endoffiehal ceils covering an intravascular ffirombus
migrated from adjacent healthy endothelial wall. Wiffi the recent discovery of circulating
progenitor ceils, both the origin of the ceils that repopulate to coat the surface of the
thrombus, as well as lime the channels within the thrombus ïs now under considerable
scrutiny. Both vessel-wall denved as well as circulating endothelial ceils express
endothelial-specffic markers, including CD34, VEGFR2, Tie-1, Tie-2, VE-cadhedn, E
selectin[96], and currendy it is not possible to distinguish panetal from circulating
endoffielial progenitor ceils.
In this thesis, I duly acknowledge the controversy surrounding the origins of -SMA+ and
endothelial ceils, and categotize the ceils mvolved in the endovascular treatment response
into endothelial, neointimal, and circulating ceils.
1.4.2.1 Endothelial ceits
Endoffielial ceils are specialized epithelial ceils that form a monolayer bamer between
flowing blood and the blood vessel wall. The endothelium is supported by a basal lamina,
winch rests on a thin layer of fibro-collagenous support tissue separating the intima from
the vascular smooth muscle ceils. The endoffielium plays a key role in vascular
homeostasis, modulating vascular tone, caliber, and blood flow in response to humoral,
neural, and mechanical signais.
In general, the function of the endoffielium varies, depending on the state of the
endothelial ceils. In the basal resting state, the endothelium forms a non-thrombogenic
layer, and secretes various vasoactive substances, including minc oxide (NO) [97]. Niinc
oxide, in addition to its vasodilatory effects, also modulates inflammation, platelet
activation, and thrombosis[97]. Furffiermore, NO counteracts leukocyte-endothelium
adhesions, VSMC proliferation, and platelet aggregation[97]. In response to appropriate
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chemical or mechamcal signais (usually signaling dismption of endothelial integrity),
endothelial ceils adopt an activated state by altering their genetic expression. There are
several consequences of this phenotype switch: endothelial ceils secrete growth factors
and trigger signaling cascades affecting adjacent endothelial ceils and VSMCs, resuHng in
ceil migration and proliferation. These signais ftirther lead to extracellular mattix
degradation to facffitate ceil migration. Finally, endothelial ceils alter their surface
molecular expression proffle. Upregulated surface adhesion molecules senTe to arrest
circulating ceils, including platelets and leukocytes, to participate in the process.
The intravascular thrombus formed witbin an aneurysm (usually following endovascular
treatment, although spontaneous aneurysm thrombosis can occur) unclenches a seties of
chemical signais that resuks in, among offier things, endoffielial ceil activation. The
presence of endothelial ceils witbin the ensuing chemical milieu of the maturing dot is
associated with incomplete aneurysm healing and recunences [93, 98]. The expression of
non-thrombogenic and thrombolytic surface molecules by endoffielial ceils within the dot
bas been suggested to coninbute to tEe process of recana]ization and aneurysm
recunence[93J. Following endovascular therapy, tEe non-endothelialized portion of tEe
maturing dot exposed to blood flow presents a potenfially thrombogenic surface. Efforts
to promote early endothelial coverage of tEe dot have been suggested as a strategy to
decrease thromboembolic complications[28, 91]. However, strategies tEat promote early
re-endothelializaflon may also increase recurrence rates by prematurely populating the dot
with endoffieliaEzed channels.
In our publication, we used CD34 as a marker of ceils of endothelial lineage, hoping to
follow tEe process of formation of endotheliakzed channels within tEe tErombus. We
hypothesized that CD34 expression would increase steadily wiffi time as channels became
lined, and then p’ateau. We further hypothesized that the effects of stenting on
mechanotransduction would decrease tEe ability of these channels to form, a difference
tEat we hoped would be reflected in CD34 expression.
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1.4.2.2 Neointimat cetLs
11e origin of die oc-smooffi muscle actin (Œ-SMA) positive ceils found within die
neointima remains unclear (see section 1.4.2). Vascular smoodi muscle ceils and
myoflbroblasts are the most widely accepted candidates, alffiough there is evidence that
monocytes may also transdifferentiate into oc-SMA+ cells[79]. One explanaflon is that
following vessel injury, different types of local ceils as weil as arrested circulaling ceils
respond to local signals and revert to a ‘defau]t’ ceil type best suited to die repair
process[99]. Under tins concept, it is possible for ail tbree ceil types to contribute to die
body of &-SMA + ceils observed wiffiin die neointima.
In this work, we assayed for die expression of Œ-SMA mRNA. In an arteri2i balloon
mjury model, smooth muscle ceils are known to begin to proliferate in the media after
approximately 24 hours [100]. Afrer 4 days, diey niigrate into the intima, where diey
continue to proliferate and form extraceilular matrix, a process which continues until
steady-state is reached at 3 months, at wbich point die intima is estimated to comprise
20% ceils and $O% matrix [101]. Recent work suggests diat other ceil types may also play
a significant role in this process [102, 103]. In a porcine vascular thermal injury model
diat quantifled macrophage and myofibroblast ceils at the site of injury, die appearance of
these other ceils types was found at 14 days, and continued to increase until 2$ days [7$].
In our work, we hypoffiesized diat stent deployment would lead to an increase in -SMA+
ceils within die neointima that would peak at 4 days and continue to steadily increase over
time, diereby resembling an arterial balloon-injury response.
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1.4.2.2.1 Vascutar smooth muscle cetls
Vascular smooth muscle ceils (VSMCs) are higffly specialized ceils whose principal
function is contraction and regulation of blood vessel tone, diameter, blood pressure, and
blood flow distiibuflon[104]. In die cardiology restenosis and adierosclerosis literature,
VSMCs are typically described in terms of two phenotypes, contractile or synthetic.
However, VSMCs have many different functional states, each with varied molecular
expression proffles. VSMC plasncity furdier conttibutes to the difflculty of accurately
determining ceil of otigin witbin neointimal tissue[104]. According to one paradigm,
VSMCs change phenotype in response to local environmental cues, including growdi
factors/inhibitors, mechanical influences, ceil-ceil and ceil-mattix interactions, and vanous
inflammatory mediators[104J. In response to these cues, VSMCs “switch” to a more
synthetic phenotype and secrete extracellular mattix, and migrate towards die vessel
lumen. VSMCs thus serve to repair the injured vessel and to confer more ngidity to die
vessel wall. According to anoffier paradigm, die presence of specific growth factors, such
as vascular endodielial growth factor (VEGF) or platelet-derived growth factor (PDGF)
can lead adventitial flbroblasts, endothelial ceils, or arrested circulating progenitor ceils to
differenfiate into VSMCs [99].
It seems diat for an aneurysm to become completely occluded, die fundus and neck of the
aneurysm must be completely lled with extracellular mattix prior to re-endothelialization
of the dot surface. Precise control of VSMC syndiesis of extracellular mattix may
facifitate die formation of die correct amount of organized tissue to completely obliterate
aneurysms.
1.4.2.2.2 Myofibroblasts
Myoflbroblasts are higliy specialized mesenchymal ceils that play a central role in tissue
repair[1 05]. Current thinking is diat myoflbroblasts are detived from flbroblasts, which
popukte die arterial adventida[99, 105]. One chemical signal triggeting die phenotypic
transformation from flbroblast to myoflbroblast lias been shown to be TGF-f31, although
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the mechamsm remains obscure[105]. Myofibroblasts also express Œ-SMA, contribuling
to die controversy surrounding the origin of ceils found within die neointima (see section
1.4.2). The primary mie of diese ceils is to close die open space witbin the aneurysm body
through die production of extracellular matrix and contraction of the organi2ing
tbrombus to contribute to die process of re-establishing die arterial lumen.
1.4.2.3 Cîrcutating ceils
Platelets and leukocytes are die classic circulatmg ceils involved in the response to vascular
injury. However, recent animal and some human evidence is accumulating that stem ceils
detived from mesenchymal or bone-marrow sources may seed tissues and contribute to
die maturation of intravascular thrombus, to angiogenesis, endothelialiaaflon, or
recanaliaation.
1.4.2.3.1 Ptatelets
Platelets are reieased from die bone marrow into die bioodstream to survey the integrity
of die vascular system, and respond to breaches by becoming activated, degranulating, and
forming aggregates adjacent to injured endothelial ceils or exposed extracellular matrix
elements [74]. During die process of activation, platelets form a procoagulant surface,
stimulating die formation of thrombin and fibrin[74, 106].
Piatelet degranulation releases multiple factors, including preformed ADP, serotonin, and
thromboxane, which further promote thrombosis[107]. The ensuing moiecular cascade
signais leukocytes to roil and arrest on endodielial ceils and migrate into tissues to repair
injury, contributing to iow-grade inflammation in die area.
The role of platelets is not solely pro-thrombotic; platelets and endoffielial ceils aiso
release miiÏc oxide which prevents platelet adherence to die vessel wall, diereby providing
a necessary neganve feedback mechamsm [107]. Platelets also release PDGF, which
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further serves to inhibit thrombosis [93, 98], and plays an important role in VSMC
migration and neointima formation. Platelets are also a source of TGf-31, winch is
involved in both neointima formation and angiogenesis.
The formation of thrombus is the sine qua non of a good endovascular outcome. An
aggregated mass of platelets and fibrin is required to form the initial provisional matrix for
subsequent cellular invasion to form neointima at the neck and organization witbin tEe
body of tEe aneurysm. However, platelets are also the main culpnt in thrombotic
complications following the introduction of intravascular devices. Thus, in clinical
practice, tEe use of indwelling intravascular devices such as stents require tEe use of two
antiplatelet agents, acetylsalicylic acid (ASA) and clopidogrel (Plavix) to irreversibly inhibit
platelet function. ASA irreversibly blocks the formation of platelet thromboxane A2,
winch inhibits platelet aggregation, while clopidogrel leads to irreversible blockade of
ADP receptors on the platelet surface, inhibiting platelet aggregation, fibrin cross-linking
on platelets, as well as inhibiting tEe glycoprotein IIb/IIIa paffiway. While tEese agents
may minimize initial thrombo-embolic complications, tEey could conceivably modulate
subsequent healing or recanalization.
1.4.2.3.2 Leukocytes
Following vessel injury, circulating leukocytes respond to released chemokines and locahze
to tEe site of injury, where they become activated. Leukocytes, particulafly neutrophils,
contribute to tEe inflammatory component of tissue healing by upregulating expression of
adhesion molecules and releasing vasoactive substances sucli as oxygen-derived free
radicals, proteolydc enzymes, growffi factors, cytokines and chemokines[77]. These
substances can play a nefarious role by perpetuating further injury, botE direcily and by
further activating leukocytes. However, ffiey can also contribute to healing by stimulating
VSMC proliferation and neointima formation[77].
Monocytes (CD14) are immune ceils that differentiate into macrophages following their
migration into tissue, and are commonly found within the substance of the neointima[78].
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Monocytic/Macrophage (MC/Mph) ceils participate in neointimal formation by releasing
cytokines, metalloproteinases, and growdi factors[861. In die presence of high levels of
MCP-1, MC/Mph ceils have been shown to form “tunnels” within thrombus[941, creating
conditions necessary for recanalization of arterial or venous dot. The formation of diese
tunnels through organizing dot allows for die te-establishment of blood flow following
intravascular occlusion. In die case of formed dot inside a treated aneurysm, die tunnels
dius formed may be die beginning of an aneurysm recurrence, requiring appropriate
hemodynamic and chemical stimuli for furdier growth and development. The process of
channel formation within die thrombus, termed recanalization, shares conceptual and
theoretical sirriilarities with angiogenesis; dues to die molecular mechanisms occurring
during aneurysm recurrence may be found by looking for known angiogenetic factors.
More recently, diese ceils have been hypodiesized to have die capacity to transdifferendate
into eidier myofibroblasts or endodielial ceils, reviving die old pathological paradigm of
bone-marrow origm for these ceils [10$].
1.4.2.3.3 Progenitor cetts
Following endovascular treatment, circulating progenitor ceils may arrest at die treatment
site and differenfiate into endodielial ceils to contribute to die process of re
endoffie]ialization/recanalization, or into Œ-SMA+ ceils diat populate die neointima and
contribute to die formation of extracellukr matrix. Mesenchymal progenitor ceils
(CD34j can differenfiate into bodi neointimal and endothelial ceils, while recently, a class
of CD34CD14 ceils denved from bone marrow mononuclear ceils have been identified
diat are also able to differentiate into endodielial ceils.
1.4.2.3.3.1 Mesenchymat progenitor cetis
Mesenchymal progenitor ceils (MPCs) exbibit a high degree of plasticity, and can
differentiate into several tissue types, including VSMCs and endothelial cells[109]. MPCs
32
can be isolated from bone marrow, umbilical cord and penpheral blood[109, 1101.
Differentiation of MPCs depends on the presence of approptiate physiologic signais,
wbich includes PDGF and proper ceil-ceil couphngs[109]. Circulating MPCs may seed
the tunnels formed by monocytes and differentiate mto endothelial ceils to une the
channels found within maturing thrombi[79].
1.4.2.3.3.2 Endothetial progenitor ceits
There are at least two classes of circulating endothelial progemtor ceils (EPCs), CD34
(derived from MPCs) and CD34CD14 ceils (derived from bone-marrow mononuclear
ceils (BM-IVINCs)). These ceils are able to integrate into the vasculature of tissue
undergoing repair, parficipate in angiogenesis, and may contribute to the process of
recanalization[68j. As with MPCs, the differentiafion and behaviour of these EPCs into
endothelial ceils is determined by their cellular milieu[68]. The regulation of
differentiaflon of these ceils is complex, involving ceil-matrix interactions, secreted soluble
factors, resident vascular ceils, and petipheral blood mononuclear cells[681. These
regulatory factors interact and modulate the effects of one anoffier and are ffiemselves
further regulated by physiologic stimuli, including mechanical forces.
Because boffi panetal and circulatmg endothelial progenitor ceils express die same cellular
markers, there is no recognized means to distinguish these ceil types[96]. This is further
complicated by die fact that subsets of hematopoietic ceils express markers similar to
those of endothelial ceils sucli as CD34, PECAM, vWF, VEGFR2, Tie-1 and Tie-2.
Therefore, die relative contribution of endothelial progenitor ceils to die process of re
endothelialization/recanalization followmg endovascular freatrnent remains unclear, but
offers an alternative hypodiesis to die otigin of the endodielial ceils found within die
matunng thrombus.
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1.4.3 ExtraceLlular matrix
The extracellular matrix (ECM) is made up of collagens, structural glycoproteins, and
proteoglycans[111], and is primarily produced by VSMCs and fibroblasts[1121. The ECM
makes up an estimated 80% of the neointimal volume[1O1], and ECM components also
form basement membranes and the internal elasiic lamina. These layers serve as structural
support for ceils, but also form barriers between tissue compartments regulating the
cellular migration. The ECM acts as a substrate for ceil adhesion, spreading, and
migration, and is important for the growth, differenfiation, and survival of adherent
cells[60, 113, 114]. As evoked in section 1.4.2.3.1, die pertinent matrix at die level of the
lumen of die aneurysm as well as at die ostium is continuously evolving as a result of
cellular migration from die provisional platelet-fibrin dot to die more mature matrix
found in die neoindma at the neck and die organizing dot in the fundus of the aneurysm.
Following endovascular treatment, an injury repair program is initiated, which leads to
migration and proliferation of ceils to and witbin die neoiniima, along with active
secretion of extracellular matrix.
The newly secreted extracellular matrix can be covalently linked to neointimal ceils via ceil
surface integrins, wbich sense die integrity of die surrounding matrix. In this manner,
ceils can be provided wiffi directional guidance dues for migration[60]. The linkage
provided by die ‘-SMA+ ceils-integrins-collagen’ network also allows matrix contraction,
as shown in fibrin gel and collagen gel cultures of VSMCs [115]. The fluidity of the matrix
can be modulated by die balance of activity of a class of proteases known as matrix
metalloproteinases and dieir inhibitors.
1.4.3.1 Matrix metaLLoproteinases and their inhibitors
Matrix metalloproteinases (MMPs) are zinc-dependent enzymes diat degrade ECM
components under physiological and padiological condidons[116]. There are 24 identifled
members of die MMP family, classifled into 4 groups, including die coflagenases,
gelatinases, stromelysins, and membrane types (MT-MI’vWs) [117]. MMPs, particularly
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MT-MMPs, are also essential to endodielial ceil migration mto fibrin gels[118]. 0f these,
the gelatinases IVIIVfP-2 and MMP-9 are most important to us, because diese enzymes
degrade denatured fibrillar collagens (gelatin), including elastin [119]. These potent
proteolytic enzymes are secreted by a vanety of ceil types, mcluding endodielial ceils,
VSMCs and macrophages [116]. MMPs activity is countered by another group of enzymes
known as die tissue iriluibitors of metalloproteinases (IIMPs)[116, 120]. The balance of
MIvIP and TIMP activity controls the diffusion of substances and die migration of ceils
througli die ECM. These proteinases also modulate signal transduction padiways by
acting on a wide variety of substrates, including inflammatory mediators, growth factors,
and growth factor receptors [120].
Considerable work lias been done to elucidate die ldnedcs and expression of IvflVfP-2 and
M1VW-9 under various experimental conditions. In an in vivo model of a surgically
created artenovenous fistula resultmg in increased shear stress, MMP-2 and MIv1P-9 levels
were found to be elevated; N’EVFP-2 levels peaked at 2 days and remained elevated,
whereas I\’[MP-9 levels peaked at 2 days and then quicldy decreased[121]. This result was
interpreted as a response of MIVWs to degrade die basement membrane and bodi permit
ECs to migrate into a larger area and to permit VSMCs to migrate and te-orient
diemselves to adapt to arterial enlargement, widi MMP-2 playing a more lasting role, and
IvilvfP-9 liaving more transient effects[121]. Subsequent in vitro work has shown Iv[MP-9
expression to 5e responsive to die shear pattem, widi oscillatory or turbulent blood flow
resulting in greater, sustained expression compared to unidirectional shear, winch
demonstrated a lesser, more linuited increased expression [122]. Arterial balloon injury
and subsequent remodeling increase die production and activation of MMP-2 and MI\4P-9
[123, 124]. MMP-9 has also been localized to adierosclerotic plaques in humans[125J.
Anodier model, testmg die effects of transient low flow on a background of chromcally
elevated bigli flow, showed increased MMP-2 expression while MMP-9 expression
decreased[126]. Perhaps die model most similar to ours is die variable flow model of
Bassiouny et al., where animals with experimentally decreased blood flow showed
increased MMP-2 expression [127].
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MIvIP-9 is also essential to angiogenesis. Deficient angiogenesis in MMP-9 / mice cari be
rescued by bone marrow transplant of MMP-9 ceils, supporting a role for both MMP
9 and circulating ceils in ffie formation of new vessels, or even recanalizaflon[128].
We hypothesize that stenting will lead to decreased flow entering the aneurysm, wiffi
subsequent increases in IvIMP-2 and MMP-9 expression. An increase in TGF-f31, wbich is
known to increase MI\’FP-2 and MMP-9 expression[1291, may further increase the levels of
these IVfMPs. As observed wiffi the bigh shear models, we anficipate that the increase in
MMP-9 will be of brief duraflon, whereas that of MMP-2 will be more sustained.
The expression of the TIMPs is closely related to IvilvfP expression; tight regulatton is
essential for these potentially higliy destructive enzymes. In response to appropriate
stimuli, including mechanical stress, the balance between MMP and TIMP acflvity can be
altered, resulting in increased mattix degradaflon. We hypothesize that the changes in
mechanical force caused by the stent, in conjunction with die released molecular
mediators, will lead to either changes in TIMP expression in the same direction, but at a
lesser magnitude, than MMP expression, or increased MMP expression and decreased
TIMP expression.
1.5 REGULATION 0F THE VASCULAR RESPONSE TO INJURY
The vascular response to injury is a seties of coordinated events involving many different
ceil types, driven and regulated by locally released mediators, ceil-ceil and ceil-mattix
adhesions, and transduced mechanical forces.
1.4.1 Soluble factors
There are a plethora of soluble factors potentially involved in die locali2ed response to
endovascular therapy, which function by alteting die molecular expression of ceils
exposed to their effects. Binding and expression kinetics of diese cytokines are further
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dependent on ffie affinity of the receptor for the soluble factor, which in tum can also be
influenced by offier cytokines [130]. The differences in pleiotropy, dose-dependence,
binding kinetics, and potential multiple interactions of the soluble factors produced by the
different ceil types of this in vivo aneurysm model (described in more detail in section
3.3.1) amounts to considerable molecular complexity. For purposes of simplification, I
chose to focus on the soluble factors PDGF-BB, TGF-Ç31, MCP-1, and TNF-Œ, which are
known to be important to vascular injury repair, dot organi2ation, and neointima
formation[l 31-l 33).
In the molecular portion of this thesis, we attempt to quantitate and compare the level of
mRNA expression of these cytoldnes by ceils within aneurysms in the experimental
(stented) and control groups. It is difficult to predict die effects of stenting on mRNA
expression due to the number of potential confounders in tins macro transiaflonal
research model. Achieving expedmental isolation is difficult at best; confrofling for
potential sources of bias is also difficuit. Yet experiments such as diese offer die promise
of demonstraling which cytoltines are the best candidates for future expeidmental
manipulation in hopes of improving outcomes following endovascular therapy. What
follows is a brief description of four soluble factors we ffiought were most likely to be
involved in regulating die endovascular treatment response.
1.5.1.1 Ptatetet derived growth factor-BB
Platelet derived growffi factor (PDGF) is a potent chemoattractant and mitogen produced
by activated platelets and macrophages diat stimulates VSMC proliferation and
migration[104J. PDGF is a composed of variable combination of A and B chains hnked
by a disuffide bridge, resulting in three different isoforms (AA, BB, AB). PDGF initiates a
signa]ing cascade following binding to their tyrosine kinase receptors PDGFR-oc or
PDGFR-[3 [104]. PDGF stimulates monocytes/macrophages to produce odier cytokines,
including TGF-p1[134]. PDGFR-f3 signaling, mediated by PDGF-BB, is important to
neointima formation, because it stimulates VSMC migration and proliferation[104, 135].
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Experiments to surgically manipulate blood flow in vivo show diat the levels of PDGF
BB expression are increased in response to reduced flow [136]. In vitro, cukured
endothelial ceils increase their expression of PDGF-BB in response to acute increases in
shear stress or turbulent flow [137]. However, chronic exposure to shear stress suppresses
PDGF expression[138]. Cydic strain (section 1.3.3.1) also increases PDGF
expression[71J. We hypodiesize diat stent deployment across die aneurysm neck will
acutely disrupt blood flow into die aneurysm, leading to turbulent flow and increased
PDGF-BB expression. Stenting likely also decreases cycic strain, by limiting die radial
force applied to die vessel wall, winch we hypodiesize will decrease PDGF-BB expression.
The net effect of diese conificting stimuli on die genetic expression and formation of
neointima awaits experimentation.
1.5.1.2 Transforminggrowth factor-81
Transforming growffi factor-1 GF-f31) has been descnbed as a multifunctional
regulator; its actions are dependent on species, ceil phenotype, growdi conditions, and
interaction widi other growffi factors[121, 139]. It plays a central role in normal
development, tissue repair, as well as some padiological processes. Depending on die
type of model being studied, TGF-p1 exerts different effects: in normal arteties, TGF-(31 is
adieroprotective, stimulating proteoglycan formation and inhibiting VSMC
prohferation[140, 141], whereas in die settings of adierosclerosis and restenosis, it
promotes lesion formation, by promoting VSMC proliferation and inducing ECM
flbrosis[142, 143]. TGF-[31 expression changes occur within 24 hours[144] in response to
many different stimuli, including changes in shear stress [126]. In general, increased shear
stress leads to increased TGF-31 expression, aldiough intennittent decreases in shear
stress in a artetiovenous fistula model chronically exposed to high shear stress also caused
an increase in TGF-f31 [1261.
TGF-f31 can exert its effects by stimulating VSMC proliferation, increasing ECM protein
syndiesis, and alter acdvity of MMPs to facilitate die migration of flbroblasts and
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macrophages [105, 145]. TGF-p1 can also promote endoffielial ceil and VSMC
differentiation[1 04, 144].
Ceils recovered from the necks of treated experimental aneurysms have been shown to be
TGF-1 sensitive, and local delivery of TGF-p1 can increase neointimal tbickness[146}.
TGF-f31 may promote aneurysm healing by increasing extracellular matrix deposition and
over-expression of TGF-f31 has been considered as a treatment strategy[147].
In particular, we seek to characterize the effects of TGF-[31 on neointima formation within
experimental aneurysms. Because both increases and decreases in shear stress increased
TGF-f31 levels, we hypoffiesize that stenting will increase TGF-31 expression and augment
neoindma formation.
1.5.1.3 Monocyte chemotactic protein-1
Monocyte chemotacdc protein-1 (MCP-1) is a potent and specific activator of monocytes
and basophils that promotes monocyte migration[148]. MCP-1 is secreted by vascular
ceils, including endothehal ceils, VSMCs, and fibroblasts, to attract circulatmg monocytes
to the arterial wall[148, 149], where they promote neoindma formaflon[150, 151]. MCP-1
is implicated in the initiation and progression of affierosclerotic lesions, as well as in
neointimal hyperpiasia following balloon injury[152].
The role of MCP-1 in the evolution of intra-vascular thrombus is of particular interest to
our work. In the presence of high levels of MCP-1, monocyte/macrophage ceils have
been shown to form “tunnels” witbin thrombus, creating conditions necessary for the
seeding of circulating progenitor ceils which subsequendy organize and potentially
recanalize maturing dots [94] (see section 1.4.2.3.3.2). Factors winch increase MCP-1 may
not only increase neoindma formation, but also promote dot recanalization and
predispose endovascularly treated aneurysms to recurrences.
The expression of MCP-1 is known to be responsive to shear stress[153]. The
introduction of laminar shear stress to cultured endoffielial ceils induces a biphasic
39
response of MCP-1 expression, peaking at 1.5 hours and dien returuing to baseline by 4
hours [154]. Steady laminar shear stress continued for greater dian 5 hours leads MCP-1
expression to become completely quiescent. Continued laminar shear stress is thus
diought to be atheroprotective by reducmg MCP-1 expression [153]. The complexity of
die molecular milieu is further mcreased by in vitro work winch demonstrates variability
of MCP-1 expression in response to changes in temporal gradient of die ftow profile to
winch endodielial ceils are exposed[155].
In our aneurysm model, the blood flow entering die aneurysm is flot laminar [66]. We
hypodiesize diat MCP-1 expression will be increased by die dismption of blood flow
caused by stent placement across die aneurysm ostium. We anticipate diat die tise in
MCP-1 will correlate widi increased neointimal formation witbin die aneurysm. Also
hkely affecting MCP-1 expression at die level of die aneurysm in our in vivo model wffl be
die local cytokines TNF-o and PDGF, winch have been shown to upregulate MCP-1
expression in cultured endoffielial ceils [156].
1.5.1.4 Tumour necrosis factor-u
Tumour necrosis factor-Œ ÇT’Nf-&) is a pro-inflammatory cytokine produced by
macrophages, neutrophils, endothelial ceils, and VSMCs [157, 158]. TNF-Œ acts on a
variety of ceil types and exerts multiple biological effects. TNF-Œ is known to upregulate
die expression of die adhesion molecules, including VCAM-1, and MCP-1 winch furdier
attract leukocytes to die area. TNF-Œ can also alter die expression of growth factors,
modulate endodielial ceil apoptosis, and stimulate MMP activity[158, 159].
Circumstantial evidence from balloon-injury models of restenosis also implicate TNF-Œ
activity in formation of neointima[160]. TNF-Œ expression by medial VSMCs precedes
dieir proliferation [161], and TNF-Œ levels have been found to be elevated in
adierosclerotic artery segments [162]. Finally, die addition of a TNF-Œ antagomst has
been found to diminish neointima formation in rabbits [163]. Aldiough die precise
mechanism of action remains obscure, die downstream effects of TNF- mediated
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signaling are begrnning to be understood [164, 165]. Laminar or high shear stress is
known to inhibit production of tins cytokine[1 601, while areas of turbulence or iow shear
stress, where atheroma forms, have bigh TNF-c levels [1 30].
Concerning experimental aneurysms, turbulent blood flow or low shear stress augments
TNF-Œ expression, and we hypoffiesize that stenting will increase the turbulence of blood
flow into the aneurysm and increase TNf-Œ expression. We further anticipate the tise in
TNF-Œ will increase VCAM-1 expression.
1.5.2 Adhesion Molecutes
1.5.2.1 Ceti-ceiL interactions
Cellular interactions are ctitical events in vascular biology, resulting in intercellular
adhesions and trans fer of information through signaling pathways. Specffic molecular
mechanisms govem these interactions, the simplest of wbich involves an adhesion
molecule of one ceil binding the counterligand of another[166]. This binding of ceils
togeffier can transmit nuclear signais winch alter cellular function. Many intercellular
adhesion molecules have been identified, but for the purpose of this thesis I will focus on
those assayed experimentally, winch are VCAM-1 and PECAM-1 (CD31).
Integrins also mediate adhesions between cells[1671; however, the majotity of their
interactions are with the extracellular mattix; integrins are discussed in section 1.5.2.2.1.
1.5.2.1.1 Platelet endothelial ceti adhesion motecute-1
Platelet endoffielial ceil adhesion molecule-1 (PECAM-1), also known as CD31, is a
glycoprotein expressed on the surface of platelets, monocytes, neutrophils, macrophages,
and some T lymphocytes[168], and is involved in leukocyte aggregation and endothelial
leukocyte interactions [69]. In solitary ceils, PECAM-1 is diffusely distributed across the
cell surface, but once a ceil-ceil contact is made, PECAM-1 localizes to the ceil-ceil
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juncdon[1 69], wbich bas been shown to be the site of greatest tension within the
membrane when shear stress is applied [170]. M the ceil membrane, PECAM-1 is
reported to participate in at least twa important mechanosensory complexes; flrst,
inmolecular complex with VEGFR2 and vascular endothehal ceil cadherin, winch
responds to shear stress via the phosphorylation of a PECAM-1-associated kinase,
initiating nuclear signaling[171]; and second, a complex with endoffielial nitric oxide
synthase (eNOS), winch responds to high levels of shear stress by producing NO to
vasodilate the blood vessel[172].
PECAM-1 is thus both an essential component of endothelial ceil junctions and a
modulator of various biological processes, including wound hea]ing, thrombosis,
inflammation, ceil adhesion, and signal transducflon[168]. However, PECAM-1
expression does not change in response to shear stress[173, 174], and the expression levels
were used as an internai control in our stenting experiments.
1.5.2.1.2 Vascular ceti adhesion molecule-1
Vascular ceil adhesion molecule-1 (VCAM-1) is expressed on endoffielial, epithelial,
macrophage, and dendritic cells[175], where it serves to bind those ceils expressing the
integrin very late andgen-4 (VLA-4): monocytes, lymphocytes, basophils, and
eosinophils[176]. VCAM-1 expression is increased following rat arterial balloon injury,
and is implicated in the formation of neointirna [152]. VCAM-1 expression is induced by
pro-inflammatory cytokines including INF-Œ, however, shear stress downregulates the
expression of VCAM-1 [177-179]. M areas 0f laminar blood flow, tins would confer an
affieroprotective effect, by decreasing leukocyte teffiering.
With respect ta aneurysms, we anticipated that stenfing would further reduce the shear of
the flow of blood entering the aneurysm, increasing VCAM-1 levels. We hypothesized
that tEe increased tetheting of leukocytes might promote more complete neointima
formation within the aneurysmal sac and around tEe stent.
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1.5.2.2 CeIt-matrix interactions
Ceil-matrix interactions enable several important biological processes. First, they allow for
ceil movement by providing traction for migration, by assembling extracellular matrices to
serve as tmcks for migration, and by transmitting guidance signais that serve to direct ceils
to targets[180]. Second, they form adhesions wbich allow for tissues to wiffistand
mechanical loads, and are essential to tissue integrity[1 80]. Finally, these interactions
influence ceil proliferaflon and differentiaflon through signaling pathways[61]. The
majotity of ceil-matrix interactions are mediated by ceil surface receptors known as
integrins. Integrin expression is regulated by growffi factor signaling, through interactions
with the matrix and other ceils, as well as through mechanical signaling paffiways[60, 181].
1.5.2.2.1 Integrins
Integrins are a family of ceil surface receptors that mediate tEe binding of tEe ceil to
specffic components of tEe extracellular matrix. There are at least 24 known integrins,
each recognizing several mattix proteins; conversely, most matrix proteins bind more than
one integnn[1 82]. The significance of this cellular teffier is that integrin-mediated mattix
binding can inifiate an increasingly recogmzed number of intracellular signaling cascades,
wiffi multiple downstream effects[69]. The dynamic environment of tEe extracellular
matrix is thus communicated to tEe intracellular machinery via integrins.
Integrins are involved in multiple physiological and pathological processes, including
apoptosis, tumour growth and metastasis, aneurysm formation and are likely involved in
tEe response to endovascular treatment [183]. Integrin signaling is known to modulate
MMP activity[184], and may exert tEeir effects through this pathway.
We chose to assay for mRNA expression of one integrin, ŒPjjj, which is expressed on
platelets, VSMCs, and endoffielial ceils. Like tEe other integdns, it mediates intercellular
adhesions and cell-ECM adhesions[1 85], but integrin cç3 is responsive to shear stress.
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Shear stimulates a conformaflonal change in the integrin, leading to increased binding of
ECM hgands, winch initiates nuclear signahng via multiple paffiways[171, 186, 187].
Integrin expression by SMCs in vitro is flot responsive to alterations in shear
stress [1881, but because integrin Œiii is elevated in atherosclerofic plaques compared to
controls[189], we hypoffiesize that the increased nuclear signaling or migration of ceils
through the ECM following endovascular treatment might increase integrin oç111
expression. Table 1 summarizes the hypoffiesized and observed effects of stenting on
expression of the potential genes of interest.
Table 1. Genes potenflally involved in the molecular mechanisms of aneurysm
healing, with the hypothesiaed expression changes obtained from a survey of the
literature of other vascular processes, and our experimental observations.
Expression Changes due to Stent
GENE Hypothesized Observed*
TGF-f3 t t
PDGF-BB t t
MCP-1 t
TNF-Qc t
VCAM-1 t -
MMP-2 t t
MMP-9 t t
TIMP-1 J. J.
TIMP-3 J. J.
TIMP-4 J. J.
2. RESEARCH PRESENTATION
2.1 PROJECT FRAMEWORK AND CONCEPTUAL LINKS
This ffiesis is built around a central idea; to discover novel ways to promote healing after
endovascular treatment, inspired by RudoÏph Virchow’s triad. Following work donc by
the promment German paffiologist, three risk factors for DVT/PE (deep venous
thrombosis / pulmonary embolism) formation were identifled and popularized as
Virchow’s Tnad: 1) venous stasis, 2) traumafic injury to the blood vessel, and 3)
hypercoagulable state. These factors have been widely recognized to predispose patients
to morbidity or mortality from the formation of mtra-vascular dot in the deep veins,
particularly in the lower extremity, of which portions can break off and embolize to the
lungs.
The parallels between DVI formation and endovascular aneurysm treatment begin with
the iatrogenic use of intravascular devices in an attempt to form a localized thrombus
witbin the aneurysm. We hypoffiesized that factors important to die formation of venous
dot might also apply to the formation and favorable evolution of intra-aneurysmal dot.
In this thesis, we performed experiments to manipulate two of die Virchow’s factors:
First, we used stents to alter blood flow pattems, both witbin die parent vessel as well as
into the aneurysm. Because intra-aneursmaI thrombosis is the sine qua non of
endovascular therapy, our hope was that die stent would lead to sufficient blood stasis
within the aneurysm to trigger thrombosis, and possibly mitigate any hemodynamic effects
leading to aneurysm recurrence. Second, we mecharilcally removed die endothelial lining
of die expedmental aneurysms, akin to a traumatic injury to die blood vessel, to further
incite locaEzed thrombus formation. Removal of die endodielial ceils exposes a
thrombotic surface, removes die anti-thrombotic and thrombolytic character of die
endothe]ial ceils, and further removes die signaling contribution of this ccli type to die
evolving aneurysm thrombus. Akhough we did not expeiimentally mampulate die third
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nsk factor, hypercoagulabffity, it ïs mteresting to note that locaEzed efforts to promote
coagulation have been attempted by coatmg coils with thrombogenic material[251.
By using expenmental aneurysms, we were able to observe die effects of modifying flow
(wiffi stenting) and traumafizing the blood vessel (widi endothehal denudation) on die
formation and evolution of intra-vascular thrombus, using a clinically important surrogate
end-point, angiography, but also, to study die cellular and biochemical evolution using
pathology and modem molecular techniques.
2.2 HYPOTHESES
1. The addition of endodielial denudation to the endoluminal stenting of
experimental aneurysms can improve angiographic and pathologic resuits.
2. Endoluminal stenting poses a nsk to branch vessels diat are covered by die
stent.
3. Stenting will alter die levels of mRNA expression of key molecules likely
involved in die molecular response to endovascular treatment.
4. Endothehal denudation will drasttcally modify mRNA expression afrer
stentmg (future work).
46
2.3 RESEARCH GOALS
2.3.1 General Objective
We seek to improve the clinical and angiographic outcomes of endovascular treatment of
infracranial aneurysms, by furffiering the comprehension of the biological processes
involved in the formation, organization, and evolution of intra-aneurysmal thrombus.
Identification of key ceils or molecular cascades involved the formation of stable, durable
infra-aneurysmal tissue, or conversely, those involved in undesirable effects, such as
recanali2atton, will allow us to develop new technical or molecular strategies to reduce the
morbidity and mortality of intracranial aneurysms.
2.3.2 Specific Objectives
A specific goal of this project is to understand the nature, involvement, and relative
contributions of vatious key molecules and ceils involved in thrombus formation,
organlzation, and evolution following endovascular treatment. Our endeavours focus on
the influence of stenting on cellular signaling pathways, ceil-ceil and ceil-matrix
interactions, as well as the effects of stents on enzymes that modify the consistency of the
extracellular matrix.
Additional goals include insights into the process and kinetics of intra-arterial thrombus
organization and the formation of endothelia)ized channels within an evolving thrombus
exposed to hemodynamic forces.
We also studied the effects of combiiting endoffielial denudation wiffi stenting to see how
this ceil type altered angiographic and pathologic outcomes.
On a clinical note, stents are increasingly used to treat intracranial aneurysms, in spite of
the lack of experimental support for their efficacy. A final goal is to taise clinician
awareness of die factors to consider when using intracranial stents to treat aneurysms.
3. MATERIALS AND METHODS
3.1 IN VIVO METHODOLOGY - SURGICAL MODELS
Our laboratory has developed an experimental canine carofld lateral wall vein pouch
aneurysm model. We used beagles weighing 8-12 kg. Protocols were approved by the
Instimtional Animal Care Committee in accordance wiffi the guidelines of the Canadian
Council on Animal Care. Ail procedures were performed under general anaesffiesia.
Animals were sedated with acepromazine (0.1 mg/kg’), glycopyrrolate (0.01 mg/kg), and
butorphanol (0.1 mg/kg’, and anaesthesetized wiffi intravenous thiopental (15 mg/kg).
Animais were ventllated arfificially and maintained under anaesthesia with 2% isoflurane.
Post-operative analgesia was provided for tbree days with a 50 g fentanyl patch.
3.1.1 Lateral carotid aneurysm model
Lateral carotid aneurysms were created according to the model of Gennan and Black, as
modffied by Graves[190, 191]. In 25 beagles, through a midiine incision, a portion of the
extemal jugular vein is harvested and divided into two segments of equivalent length.
Following exposure of the carotid artery, temporary vascular clips are placed to intermpt
circulation. An artenotomy is made and the vein is anastomosed to the artery in an end to
side fashion using running 7.0 Prolene suture. The fundus of the vein pouch is secured
with hemostatic clips and circulation is restored.
Following a penod of 4-6 weeks to allow the anastomoses to heal, the endovascular
procedure was perfonned. Transfemoral access was obtained, and following angiography,
a balloon-expandable stent (BX Velocity, Cordis, Miami, Florida, USA or Herculink Plus,
Guidant, Santa Clara, Califomia, USA) ranging in length from 13-33 mm and in diameter
from 3.0-4.5 mm were posifioned within the parent vessel to bridge the aneurysm neck
and deployed. The contralateral aneurysm underwent balloon angioplasty using the same
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baRbon used to expand the stent to serve as a control. Dogs have a more active
fibrinolytic system than humans, and therefore did flot receive any antiplatelet agents or
anticoagulants, as is common practice wiffi this experimental model[42]. Angiograms were
performed prior to and immediately following the stenting procedure, and pnor to
sacrifice. Twenty animais underwent a separate harvesting procedure at 4 hours (n=3), 1
day (n=3), 4 days (n6), 7 days (n=3) and 14 days (n=5) post-stenting, where the portion
of the carotid artery bearing the aneurysm was removed under anaesthesia. This was
performed to mininize the tisk of post-mortem artifacts on mRNA quality and quantity.
following successful harvesting, the animal was sactificed. The aneurysm was cut ftom
the parent vessel at the neck, and two sections were taken; a 2 mm axial section of the
neck region of the aneurysm, and a 3 mm section of the dome of the fundus. This
allowed for comparison of gene expression at the neck, where we hypothesized
mechanical signais would be greatest, wiffi that at the fundus. M the outset of our smdy,
samples were directly frozen in liquid nitrogen, but following the bigh rate of mRNA
degradation wiffi this technique, we began to immerse the tissue in Trizol (Invitrogen,
Canada) prior to freezing until biochemical analysis. An additional 5 dogs did flot undergo
this harvesting procedure; their aneurysms were designated for paffiological analysis.
following the initial stentmg procedure, they underwent angiography and sacrifice at 12
weeks and their carotid-aneurysm complexes were removed and placed in formalin for
pathological analysis.
3.1.2 Lingual aneurysm modet
The lingual aneurysm model is a modification of tEe lateral wall carotid model, where tEe
aneurysm is constructed more distally along tEe carotid artery near tEe otigin of tEe lingual
artery[1 921. The proximity of tEe branches to tEe aneurysm allows for the study of tEe
effects of stenting on branch occlusion and fiow alterations in tEe small vessels covered by
the stent.
In eight dogs, through a midiine incision, tEe extemal jugular vein was harvested and
divided into two equal parts to form vein pouches. One vein pouch was temporarily
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inverted and mechamcally scraped to remove the endothelial lining pnor to anastomosis.
On each side, die lingual nerve was idenflfied and mobilized, and temporary aneurysm
clips were applied to branch vessels. An artenotomy was created proximal to die site of
die lingual artery origin, which represents a modification from die original, where the
aneurysm was created distal to the branch. End-to-side anastomoses of the vein segment
to die artery were fashioned, with normal vein on one side, and denuded vein on die
other. The suture Une was sealed widi running 7.0 Prolene suture, and the aneurysm
pouches sealed with hemostaflc clips. Circulation was dien restored.
The endovascular procedure was performed immediately following closure of die surgical
site, as diere was no perceived advantage to await aneurysm maturation for this type of
study, as well as to mininiize die number of anaesdietics administered to die animais.
Transfemoral access was obtained, and following angiography, bilateral balloon
expandable stents (BX Velocity and BX Sonic, Cordis, Miami, Flotida) of lengths 1$-28
mm and diameters 2.5-3.5 mm were posinoned to bridge die aneurysm neck and lingual
artery, and deployed. Animais did not receive any antiplatelet agents or anticoagulants.
Angiograms were performed immediately following stent deployment, and prior to
sacrifice at 10 days (n=2), 10 weeks (n=4), and 20 weeks (n2) post-stenting. Following
femoral access wiffi catheters larger dian 5F, we performed cutdown over die femoral
artery, winch was identified and tied off. For endovascular procedures widi cadieters 5F
or smaller, simple compression of die puncture site was used.
3.1.3 Carotid bifurcation aneurysm modet
This surgical constmct features a wide-neck aneurysm at die site of bifurcation of a major
blood vessel[193]. This model more closely mimics a basilar tip aneurysm, winch is
exposed to significandy greater hemodynamic forces dian are sidewail aneurysms.
In four dogs, through a midiine incision, bodi carofid artenes were exposed and
temporarily dipped widi aneurysm clips. The left carond artery was tied off at die origin,
mobilized under die trachea, and anastomosed to die contralateral carotid artery. A
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portion of harvested extemal jugular vein, eiffier normal (n=2) or denuded (n=2), had two
slits cut longitudinally on one side, and was anastomosed to the junction of the two
carotid arteries, forming a bifurcation aneurysm (see Figure 3.1 for details). The dome of
the vein pouch aneurysm was then sealed wiffi hemostatic clips, and circulation was
restored. The endovascular procedure was performed immediately following closure of
the surgical site. Using transfemoral access, angiography was performed, and a single
balloon-expandable stent (Herculink Plus, Guidant, Santa Clara, CA) of length 18 mm and
diameters 4.0-4.5 mm were positioned wiffiin the parent vessel to bridge the aneurysm
neck and deployed. Animals did not receive any anriplatelet agents or anticoagulants.
Angiograms were performed immediately following stent deployment, and prior to
sacrifice at 5 (n=2) and 10 weeks (n=2). Following femoral access with catheters larger
than 5F, we performed cutdown over the femoral artery, winch was identifled and tied off
For endovascular procedures with catheters 5F or smaller, simple compression of the
puncture site was used.
Figure 3.1
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Construction of the wide neck aneurysm mode!. A, Artistic representation of the
preparafion of arterial and venous components. B, Construction of die Y-type carotid
bifurcation model. C, Wide neck aneurysm model. To obtain a wide neck incorporating
die origin of die left branch (left carotid artery), die distance between die proximal and
distal contact points of die lefr and dght carotid arteties is reduced to O (see text for
details). D, Intraoperadve photograph of die resulting wide neck aneurysm model. E,
Angiogram of die carotid artery, obtained inimediately afrer surgery. (Illustration by G.
Gevry and I. Salazitin. Modified from Reference [194]).
3.2 ANGIOGRAPHY
3.2.1 Laterat carotid aneurysm modet
The resuits of treatment were compared using angiography. Each aneurysm was
compared from drue of initial to nal angiography and scored as better, same, or worse,
where better implied less 1]ing of die aneurysm widi contrast material. In this manner,
stented aneurysms were compared to non-stented aneurysms widi respect to die extent of
occlusion following angioplasty widi stenting versus angioplasty alone. A typical
angiogram is presented in figure 3.2.
Figure 3.2
Angiogram of typical canine carofld lateral wall
vein pouch aneurysm at four weeks.
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3.2.2 Lingual aneurysm modet
Aneurysms were scored wiffi a nominal binary scoring system, where O indicated a
completely occluded aneurysm, and 1 indicated residual aneurysm opacification. The
incidence of branch occlusion was recorded by counting ffie number of branches covered
by the stent following deployment, and comparing to die number of branches visible at
ffiial angiography. The development of altered flow dynamics due to die stent was also
recorded. Stent-related occlusion or hemodynamic alterations were compared from
denuded to non-denuded sides. In addition, the rate and extent of in-stent stenosis was
recorded, by measuring die ratio of stent to angiographic lumen on die same angiogram
frame. Significant stenosis was considered to be a stenosis encroaching on die lurninal
diameter by greater dian 5O%, as commonly defrned in die cardiology literature[195]. A
typical angiographic image ofa lingual aneurysm is presented in Figure 3.3.
Figure 3.3
Angiogram of typical stented canine lingual
aneurysm immediately following surgical
creafion. Note die stented contralateral
artery in die background (arrows).
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3.2.3 Carotid bifurcation mode!
Aneurysms were evaluated at initial and final angiogtaphy, and given the designadon
better, same, or worse, wiffi more occluded aneurysms considered better, as with the
lateral wall aneurysm modeL
3.2.4 Efficacy of endothetiat denudation
Finally, to ensure that the segments of external jugular vein that were submitted to
mechamcal scraping to remove the endothelium were in fact de-endotheiaiiaed, we
hawested several additional external jugular vein segments from separate animais and
performed the standard denudaflon procedure, followed by fixation in formalin for
staining wiffi Verhoeff and hematoxylin-phloxine-saffton @PS) stain, and factor VIII
irnmunostaining. A segment of non-denuded vein was harvested and preserved in the
same manner for companson purposes.
3.3 PÀTHOLOGY
3.3.1 Laterat carotid aneurysm mode!
The five animais designated for pathological analysis had their aneurysm-artery complexes
flxed in formalin. Paffiological specimens were prepared by cutting the carofld artery
longimdinally, followed by “en face” microphotography of the aneurysm (Clemex,
Quebec, Canada) (Figure 3.4). For arteries bearing the stent, this included cutting though
the stent. Following photography, arteries with incorporated stents had the stents
removed to allow for thin sectioning and staining. This process unfortunately dismpts the
layer of neointima over the stent, but was deemed to be an unavoidable step to permit
further analysis. The macroscopic photogtaphs of the aneurysm orifices were flot scored,
as there were not enough samples to reach statistical significance. The images were
exarnined and used for two purposes: to validate the use of angiography as a surrogate
measure of aneurysm occlusion, and to search for correlaflons between the extent of
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padiologically confirmed aneurysm organization and biochemical resuits. The samples
were cut into serizi 5 m sections spaced 100 m apart, and stamed with HPS, Movat’s
pentachrome, and blank slides for immunohistocheniistry. Immunohistochemistry was
performed using monoclonal antibodies for smoodi muscle actin and endothelial ceils. As
with the macroscopic photography, the microscopic resuits were used to seek correlations
between the extent of aneurrsm occlusion anti biochemical proffle.
Photographs of a stented lateral wall aneurysm (on left) and an unstented control. Note
die complete neointima fomiation up to and mcorporating die stent struts on die lefr, and
die widely patent aneurysm lumen on die dght.
3.3.2 Lingual aneurysm modet
Padiological analysis was performed in ail eight animals as in die lateral carotid aneurysm
model. In die animals sacrificed at 10 days, die stents were easily removed, permitting
coronal sectioning of die aneurysms. The macroscopic and microscopic photography
were used to confinii die veracity of angiography in detemuning aneurysm occlusion.
Figure 3.4
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3.3.3 Carotid bifurcation model
In ail four animais, the stented artery was cut longitudinaily and photographed, as above.
A second longitudinal cut was made, following the arterial branch formed by the
anastomosed carottd. This furffier revealed the aneurysm ostium for photography. Axial
sections through the aneurysm dome were subsequenily stained with HPS and Movat’s
pentachrome stain, as above.
3.4 IN VITRO METHODOLOGY
3.4.1 RNA extraction
The isolation of total cellular RNA was performed according to the manufacturer’s
protocol for Trizol reagent (Invitrogen). The specimens harvested from the lateral wall
model were placed in Eppendorf tubes and immersed in liquid nitrogen. As the
experiments proceeded, to minimize loss of RNA, we began to mimerse die sample in
Tnzol ptior to fteezing. When ready for biochemical analysis, samples were diawed and
sectioned into smail pieces with a scalpel. The tissue sample was placed in a 1 mm
diameter tube with 1 ml T±ol and metal spheres, and homogenized by shaking for 4
minutes, 3 times per tube. Following mechamcal ceilular dismpdon, samples were placed
on ice. Phase separation proceeded by incubadng die homogeni2ed samples at 15°C for 5
minutes. 0.2 ml of chloroform was added to die sample tubes, shaken vigorously, and
incubated at 150 for 3 minutes. Samples were centrifuged at 12000 x g for 15 minutes at
2°C. Following centrifugation, die phases were separated, widi RNA remaining in the
upper aqueous phase.
11e aqueous phase was transferred into a fresh tube and RNA was precipitated by mixing
widi 0.5 ml isopropyl alcohol. Samples were incubated at 15°C for 10 minutes and
cenfflfuged at 12000 x g for 10 minutes at 2°C. The RNA precipitate formed a gel-like
pellet on die bottom of die tube. The supematant was removed, and die RNA washed
with 1 ml 75% edianol. The sample was mixed by vortexing and cenififuging at 7500 x g
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for 5 minutes at 2°C. Following air-drying for 5 minutes, RNA was re-dissolved in
RNAase-free water and incubated at 55°C for 10 minutes.
3.4.2 Reverse transcription of RNA to DNA
Aliquots of 1 to 3 ‘g of RNA were used for rst strand cDNA syndiesis using Supersctipt
II reverse transcriptase according to manufacturer’s instructions (Invitrogen, Canada)
followed by PCR amplifications.
3.4.3 PCR amplification
The amplification of the genes in question was performed using the primers listed in
Table 2 (at die end ofthis chapter). PCR amplifications were performed widi platinum
Taq DNA polymerase (Invitrogen) according to manufacturer’s instructions, on an
Eppendorf Mastercycler gradient, widi die following program: step 1, 94°C for 2 minutes;
step 2, 52°C to 64°C for 1 minute; and step 3, 72°C for 1 minute. Forty cycles were
performed for amplification of genes of interest, as well as for GAPDH. The
amplification for each gene was in die linear curve. PCR products were visualized on
1.5% agarose gel stained with ethidium bromide and ultraviolet transifiumination.
Quantitative analysis was carried out with a computenzed densitomefflc imager
(ImageQuant) to obtain gene to GAPDH ratios.
3.4.3 Immunohistochemistry
Five-micrometer-thick tissue sections were deparaffinized and rehydxated by passage
tbrough xylene and graded edianol and then washed twice widi 0.05 mol/l Tris HC1, 0.15
mol/l NaC1, and 0.03% Tween 20 Çf131). Endogenous peroxidase was quenched by
incubation of sections in O.3% H202 in medianol for 15 min. Ceil membrane tmethyl-D
galactopyranosyl groups specific to endoffielial ceils were detected by an anfl—GSL I
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antibody biotinylated Grffonia simpÏicijbÏia lectin 1 (GSL-1) (Vector Laboratones,
Burlingame, CA). An anflbody to -smooffi muscle actin (1:400; clone 1A4; Sigma,
Aldrich) was used to distinguish vascular smooffi muscles ceils, myoflbroblasts, artenoles
and venules from capillaries. Nonspecific binding was blocked by incubation in 10%
normal goat serum (NGS) in TBT. The primary antibodies were incubated ovemight in
TBT containing 10% NGS in a humidffied chamber and revealed by a biotin-avidin
peroxidase complex (Vectastain ABC kit, Vector Laboratoties, Burlingame, CA).
Peroxidase activity was detected with 1 mg/ml diaminobenzidine tetrahydrocifiotide and
O.l% F1,02 as substrates. Sections were counterstained wiffi hematoxylin (Vector
Laboratones) and subsequenily dehydrated in graded effianol solutions, cleared in xylene,
and mounted in Permount. Slides were visua]ized wiffi a computerized imaging system
(Vision PE, Clemex Technologies Inc., Longueuil, Quebec, Canada). Nonspecific staining
was vetifled by omission of the primary antibody or by using non-immune normal serum.
3.5 STATISTICAL ANALYSIS
Statistical analysis of the lingual model lateral wail aneurysm angiographic scores was
performed using Fisher’s exact test. The lateral wail carofld model was scored using
McNemar’s test for paired variables. For the latter case, resuits were scored as ‘better’,
and ‘same or worse’. Better was implied to mean a decrease in the amount of contrast
filhng.
Statistical analysis of the angiogtaphic brandi occlusion rates was performed using
Wilcoxon’s signed ranks test, and the in-stent stenosis data was examined wiffi
McNemar’s test.
Statistical significance for ail tests was considered when P<0.05.
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4. RESULTS
4.1 THE EFFECTS 0F STENTING AND ENDOTHELIAL
DENUDATION ON ANEURYSM AND BRANCH OCCLUSION IN
EXPERIMENTAL ANEURYSM MODELS
(Submitted to JVIR Nov 2006)
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My contribution to ffie article entitled: The Effects of Stenting and Endoffielial
Denudaflon on Aneurysm and Branch Occlusion in Expedmental Aneurysm Models
consisted of planning and executing the experiments, as well as writing the manusctipt.
During this process, I beneflted from the assistance of Igor Salazkin for the surgical
creaflon of the lingual artery aneurysms, as well as for the macroscopic and microscopic
photography of the aneurysm/stent complexes and histology slides. I performed the
angiography and endovascukr procedures in ail animals, and performed the necropsies
and tissue harvesting. I organized, prepared, and interpreted the angiographic and
paffiologic data. I beneflted from the assistance of Sophie Lerouge and Fatiha
Bouzeghrane for the immunohistochemistry of the vein and aneurysm samples. Guylaine
Gevry assisted with the formatting of images and text for online submission. Statistical
analysis was done by a dedicated biostatistician, Miguel Chagnon. Finally, Gifies Soulez
and Jean Raymond provided critical review of the manuscript.
61
I- 1t
Manuscrip Cen1ra1’
American Journai of Neuioradiology
The Effects of Stenting and Endothelial Denudation on Aneurysm and
Branch Occlusion in Experimental Aneurysm Models
Journal: American Journal of Neurocadiology
Manuscript ID: AJNR-06-00713
Manuscript Type: Original Research
Classifications: Aneurysms
ScholarOne Support: (434) 817-2040 x 167
62
The Effects of Stenting and Endotheliat Denudation on
Aneurysm and Branch Occlusion in Experïmental Aneurysm
Modets
2’3Tim Darsaut, MD; 2lgor $alazkin, MD; 2$ophie Lerouge, PhD; “2Gilles Soulez,
Ml, MSc; 2Guylaine Gevry, BSc; 2fatiha Bouzeghrane, PhD; “2Jean Raymond, MD.
‘Department of Radiology, Centre Hospitalier de l’Université de Montréal, and
2Research Centre, Notre-Dame Hospital, Montreal, CANADA and Department of
$urgery, Division ofNeurosurgery, University ofAlberta, Edmonton, CANADA.
Corresponding author:
Dr Jean RAYMOND, MD
CHUM - Notre-Dame Hospital
Interventional Neuroradiology Research Laboratory
1560 $herbrooke east, suite M8203
Montreal, Quebec, CANADA H2L 4M1
Telephone: 514.890.8000 ext 27235
Fax: 514.412.7621
Email:
63
Acknowtedgments
This work was supported by grants from the Canadian Institute of Health Research
(MOP-44062) and Fondation des Maladies du Coeur du Québec to JR. Stents were
gifis from Cordis (Johnson and Johnson Medical, Miami, Florida, USA) and Guidant
(Guidant, Santa Clara, Califomia, USA).
64
The Effects of Stenting and Endothetiat Denudation on
Aneurysm and Branch Occlusion in Experimentat Aneurysm
Modets
Number of tables: 2
Number and Types of Figures: 4 (figI, 3 and 4: CMYK 600dpi; Fig 2: Grayscale
600dpi)
Key Words: aneuiysm, endothelium, stent, branch vessel occlusion
Abstract word count: 249
Text word count: 3805
Number of references: 25
65
Abstract
Background and Purpose
Stents are increasingly used in the endovascular treatment of intracranial aneurysms. We
studied the effects of stenting and endothehal denudation on aneurysm and branch vessel
occlusion.
Methods
Bilateral extemal carotid vein pouch aneurysms were created proximal to the lingual artery
origin in $ dogs, scraping the aneurysmal endothelial Uning on one side. Boffi arteries
were immediately stented using balloon-expandable stents. Angiography was perfonned
at time of stenting and immediately prior to sacrifice, at 10 days (n=2), 10 weeks (n=4)
and 20 weeks (n2). In 4 offier dogs, a wide-neck carod bifurcation aneurysm was
created, wiffi the vein pouch denuded or not (n=2 each), followed by immediate stenting.
Angiography was performed at dine of stenting and prior to sacrifice at 5 (n=2) and 10
weeks (n=2). Brandi occlusion between initial and final angiograms was recorded.
Pathological evaluadon of aneurysm tissue fihling was smdied, with attention to neointima
formation at die aneurysm ostium and around branch vessel odgins.
Resu Its
Seven of 8 stented and denuded lingual aneurysms were completely obliterated compared
to 2 of 7 aneurysms that were stented alone (P<0.04). None of the carotid bifurcation
aneurysms became obliterated, but denuded aneurysms showed partial thrombosis. 0f 68
total stent-covered branches, 5 (7%) were occluded and 17 (27%) had altered angiographic
fiow.
Conclusion
Stenting led to suboptimal resuits in the presence of an intact endoffielial layer.
Endoffielial denudation can promote aneurysm occlusion when combined wiffi stentmg.
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Introductïon
Endovascular therapy of aneurysms can improve die outcome 0f patients treated afrer
subarachnoid hemorrhage (SAR) as compared to surgical cipping [1]. However, this
treatment moda]ity is associated with recunences and a concem for fimire hemorrhage
[2]. Attempts to decrease die recunence rate have led to several technical and
bioengineenng innovations [3-7]. One strategy involves treating the aneurysm as a
symptom of the diseased parent vessel, with deployment of a stent to bridge die aneurysm
ostium. Currendy, stenting is ofren combined with coil occlusion, hopefully to modify
intra-aneurysmal hemodynamics, provoke aneurysm thrombosis, re-establish normal
blood flow pattems within die parent vessel, and perhaps buffer die hemodynamic forces
implicated in recunences [8-12]]. In addition, die stent may provide a supportive scaffold
for neointima deposiflon at die junction of the parent vessel and aneurysm neck. The
major concem regarding this treatment strategy is the risk of stent-related occlusion of
branch or perforating vessels, and the excessive formation of neointima widi secondary
parent vessel stenosis [13]. furthermore, the use of stents alone, particularly if they are
designed to minimally affect branches and perforators, may flot sufficiendy alter
hemodynamics to initiate thrombosis and lead to aneurysm healing [14].
91e dening boundary of die endoluminal space is die endothelial lining, winch is
compnsed of a single layer of specialiaed ceils with anti-thrombotic and thrombolytic
properties important for die maintenance ofvessel patency [15]. The endothelial lining is
responsible for die persistence of expenmentally constmcted aneurysms, for residual flow
witbin die neck of incompletely treated aneurysms, and is involved in recanaUzation
following arterial occlusion [16, 17]. Endodielial denudation could be considered as a
therapeutic strategy to improve die resulis of endovascular treatment of aneurysms [17].
However, endothelial denudation in die continued presence of blood flow leads to re
endodielializatton [16, 18, 19]. Afrer denudation, hemodynamic changes provoked by
stent struts may alter re-endothelialiaation and promote aneurysm thrombosis,
organiaation, and healing in such a fashion as to redene die boundary of die endoluminal
space to one dened by die stent, diereby excluding die aneurysm. The stent may also
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lead to increased neointima formation at die site crucial for aneurysm obliteraflon, at die
parent vessel-aneurysm neck interface.
The present work sought to examine die relaflonship of stenting and endothelial
denudation to aneurysm and branch vessel occlusion, as assessed by angiography and
padiology, and to explore die potential value of a novel approach combming both
strategies to improve resuks of endovascular treatment.
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Methods
Protocols were approved by the InstituiÏonal Animal Care Committee in accordance widi
the guidelines of the Canadian Council on Animal Care. Ail procedures were perfonned
under general anesthesia. Twelve beagles weighing 8-12 kg were sedated widi
acepromazine (0.1 mg/kg), glycopyrrolate (0.01 mg/kg), and butorphanol (0.1 mg/kg),
and anesdietized with intravenous thiopental (15 mg/kg). Animais were ventilated
artificiaily and maintained under anesdiesia with 2% isofiurane. Post-operative analgesia
was provided for three days widi a 50 fentanyl patch.
For this work, the lingual aneurysm [20] and carofld bifurcation aneurysm models [21, 22]
were used, widi a modification to die lingual model. Bnefiy, for die lingual model (n=8),
the region of the lingual artery was accessed through a midEne incision. A portion of the
left extemal jugular vein was harvested and divided in haif to form venous pouches. One
of the vein segments was temporarily inverted and scraped with a scalpel blade to cause
endothelial denudation, as previously described [17]. To evaluate the extent of denudation
and damage to the jugular vein segments widi this technique, a portion of jugular vein of
four other dogs was harvested and scraped in a similar fashion, frxed in formalin and
processed for factor VIII immunostaining, Verhoeff and hematoxylin-pifioxine-saffron
(HPS) staining. Control non-denuded vein was also harvested for compatison.
On each side, die lingual newe was identified and mobilized, and temporary aneurysm
clips were applied to branch vessels. A 4mm artenotomy was created proximal to die site
of die lingual artery origin, which presents a modification from die distally located
aneurysm in die originally descnbed model [20]. End-to-side anastomoses of die vein -
segment to die artery were fasbioned, widi normal vein on one side, and denuded vein on
die odier. The suture une was sealed widi running 7.0 Prolene suture, and die aneurysm
pouches sealed widi hemostatic clips.
The endovascular procedure was performed irnmediately foilowing closure of die surgical
site. Transfemoral access was obtamed, and foilowing angiography, bailoon-expandable
stents (BX Velocity and BX Sonic, Cordis, Miami, Florida) lengths 1$-2$ mm and
diameters 2.5-3.5 mm were deployed bilateraily to bridge die aneurysm neck and lingual
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artery. Angiograms were performed immediateÏy following stent deployment, and prior to
sacrifice at 10 days (n=2), 10 weeks (n=4), and 20 weeks (n=2) post-stenting.
For the carotid bifurcation model (n=4), through a midiine incision, both caroiid artenes
were exposed and temporarily cipped with aneurysm clips. The lefr carotid artery was
tied off at the origin, mobilized under die trachea, and anastomosed to the contralateral
carotid anery. A portion of harvested extemal jugular vein, either normal or denuded, had
two slits cut longitudinally on one side, and was anastomosed to the junction of die two
carotid artenes, forming a wide-neck bifurcation aneurysm [20, 21]. Using fransfemoral
access, angiography was perfonned, and a single balloon-expandable stent (Herculink
Plus, Guidant, Santa Clam, CA), 18 mm in length and ranging in diameter from 4.0-4.5
mm was positioned in die right carotid artery, bridging a portion of die aneurysm neck
and die origin of die re-implanted left carotid artery. Angiograms were performed
immediately following stent deployment, and prior to sacrifice at 5 (n=2) and 10 weeks
(nz2). Animais did not receive any antiplatelet agents or anticoagulants.
The results of treatment were compared by angiography and padiology. Angiographic
resuits were compared using Fisher’s exact test, where P < 0.05 was required for
signiflcance. Aneurysms were scored in a binary fashion, where a score of O indicated
complete obliteration, and a score of 1 indicated residual or recurrent aneurvsm. The
number of branches covered by die stent was counted on die initial angiogram and
compared to die final angiogram to determine die incidence of branch occlusion. The
incidence of hemodynamic alterations, such as sluggish blood flow diough a branch vessel
was also recorded. The incidence and extent of angiographic in-stent stenosis was
determined by measuring die ratio of reference vessel to stent lumen on die same
angiogram ftame. Significant in-stent stenosis was defined as a reduction of luminal
diameter of greater than 50% [23].
Padiological specimens were prepared by cutting die stent/artery complex longitudinally,
followed by “en face” microphotography of die aneurysm and branch vesse1 ostia
(Clemex, Quebec, Canada). Padiological findings were studied after formalin fixation,
sagittal or coronal sectiornng, and staining with hematoxylin-pifioxine-saffron (HPS) and
Movat’s pentachrome stain. Jmmunobistochemistry was performed on illustrative cases
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with markers for endoffielial ceils (anti-GSL I anflbody biotmylated Grftonia simpticifolia
lectin I (GSL-1), Vector Laboratones, Burlingame, CA) and Œ-smooth muscle actin
(1:400, clone 1A4, Sigma, Aldrich).
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Resu Its
Endothetiat denudation procedure: Factor VIII staining conflrmed ffie denuding
procedure was effective, but ‘clusters’ of persisting endothelial ceils were occasionally
observed. Damage to the vessel wail extended to dismpfion of the internai elastic lamina
in a few regions, but no laceration of the media was observed (Figure 1).
Surgicat and Endovascutar resutts: Ail animais tolerated the operalive and stenting
procedures weil. Ail aneurysms were patent immediately following surgery. Stent
placement was judged to be saflsfactory in ail dogs.
Àngiography: Seven of $ lingual aneurysms treated wiffi stenting and endothelial
denudadon were completely occluded compared to 2 of 8 aneurysms freated wiffi stenting
alone (P=.040). Angiographic resuits are presented in Table 1, and fflustrated in Figure 2.
0f 68 branches covered by the 20 stents, occlusion was noted in 5/68 (7%), 2 of which
were on the denuded side (Table 2). Blood flow pattems were altered in 17/68 branches
(25%), 8 ofwhich were on die denuded side. Endothelial denudation of the aneurysm did
not result in a difference in die incidence of branch occlusion or aheration of blood ftow
(P=1 and .916, respecflvely).
Akhough 7/20 (35%) of stents were noted to have some neointima encroaching on the
luminal diameter, in no cases did die degree of stenosis reach SO%.
Ail denuded (n=2) and non-denuded (n=2) carotid bifurcation aneurysms were stiil patent
at final angiography. However, both denuded aneurysms showed only partial fihling, while
non-denuded aneurysms remained widely patent. None of die four ‘jailed’ lefr carotid
artenes became occluded or had altered flow dynamics, and there was no observable
neointimal hyperpiasia on the parent vessel lumen due to stent implantation.
Pathotogy: Macroscopic photography of typical resuits for lingual model aneurysms
treated widi stentmg alone and with stenting and denudation is presented in Figure 3 a-d.
The seven aneurysms diat were not completely occluded on angiography were grouped
into four types; die flrst were die large saccular recurrences (n=2, bodi non-denuded) that
were associated widi very incomplete neoiniimal coverage at the neck (Figure 3a, c);
second, smail channels extending from die parent vessel along die vein pouch wail (n1,
72
non-denuded); third, smail channels opening into larger spaces witbin ffie aneurysm
ftindus (n:z3, ail non-denuded); these channels were connected to smail openings visible
through the stent struts (Figure 3h, d); and fourth, a smail blunted neck reninant (n=1,
denuded).
Lingual model stents were wellincorporated into the arterial wall in 14/16 cases, and 3 of
4 carofld bifurcation stents were weil-mcorporated in neointimal tissue. Where stents
were observed to ‘jail’ die branch vessel origins, in cases where die osdum was patent, one
of two pattems of neointima deposition was observed. Sometimes the stent was devoid
of neointima, while in others, die strands of material covered portions of the stent struts,
with the ostium patent undemeath (Figure 3g, h). In some cases die neointima was seen
to have grown over and occluded die branch vessel origin.
Bodi non-denuded wide-necked carotid bifurcation aneurysms remained widely patent,
but smaller aneurysms partially occluded widi organized dot were observed in both cases
treated with stenting and denudanon (Figure 3i).
Staining for Œ-smooth muscle actin confumed die presence of numerous myoflbroblasts
witbin die organi2ing thrombus (Figure 4a). Endothelial ceil-specific staining widi GSL-1
showed lined crevices within die organized thrombus (Figure 4b).
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Discussion
The use of stenting alone was ineffective at totally occluding both lingual and carodd
bifurcation aneurysms, at least wiffi die devices we used. Alffiough blood flow patterus
were sufflciently modified to provoke thrombosis and dot organization within the lingual
aneurysms, the use of the stent alone did flot produce a solid organized structure
completely obliteratmg die aneurysm. When die endoffielial liriing was preserved, small
endothelial-llned crevices, which have been associated with recunences [16, 17], were
observed in most cases. However, when stenting was combined with endothelial
denudation, occlusions were more often complete and intra-aneurysmal tissue more
organized. Removal of the endodielial lining may incite a more vigorous tbrombotic
reaction witbin die aneurysm, by exposing a greater collagenous surface. AltemativeÏy, the
removal of endothelial signaling may limit or prevent the formation of residual or
recunent crevices. In die future, endothelial denudation could theoreflcally be
accomplished with mechanical, physical, or chemical means. Although denudation
removes parietal endoffielial ceils, circulating endodielial progenitor ceils have been
descnbed, and likely participate in the repopulation of die maturing ffirombus[24].
Attempts to replicate the resuhs of die lingual model in high-flow wide-neck bifurcation
aneurysms were unsuccessful. Notably, die stent does not completely cover die aneurysm
ostium in this model, and die thrombus is exposed to greater hemodynamic forces. These
conditions seem unfavorable for die formation and organization of intra-aneurysmal dot.
Aneurysms such as diese may require new devices such as bifurcated stents wiffi
asymmetrical ceils or different dierapeutic strategies for definitive treatment.
One difftculty widi die use of intracranial stents arises from die confficting goals of
provoldng aneurysm thrombosis while sparing adjacent branches. Ideally, die portion of
die stent coveiing die aneurysm would be of low porosity, widi minimal blood flow into
die aneurysm, widi die remainder of die stent compnsed of high porosity stent ceils.
Smaller pore sires may protect die organizing dot from hemodynamic forces and
promote neointimal proliferation up to die boundary created by die stent, permitting
greater neointimal formation at die junction of die parent vessel and aneurysm neck.
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High-porosity stents such as those cunendy available for intracranial use are more hkely to
preserve perforating vessels, but require an additional treatment, usually coiling, to occlude
die aneurysm.
The varying observations at the level of die stent stmts crossing branch vessel ostia may
represent three different padiological outcomes: a) branch vessel thrombosis widiout
recanaii2aflon, widi dense neointimal coverage; b) brandi vessel thrombosis with
recanalization, widi non-uniform tissue strands covering die stent struts; c) branch vessel
remains patent, widi bare stent struts crossing a vessel origin. In this series, the use of
stents led to brandi occlusion in 7.3% of cases, and endodielial denudation of die
aneurysm did not worsen this rate. However, stent-related blood flow alterafions were
observed in 25% of cases, which raises concems about stent-related tissue isciemia or
infarcflon. The ffiiding of exposed portions of die stent crossing vessel ostia further
stresses die importance of compliance widi long-term platelet dierapy followmg stenting.
Although in-stent stenosis did not occur widi die stents we used, c]inical reports of dus
complication mandate condnued surveillance until die natural history of intracraniil
steniing is better delineated [251.
Experimental Limitations:
The advantage of die lingual aneurysm model is die multiple brandi vessels diat resemble
many intracranial aneurysms. Aneuxysms in this position are exposed to lesser
hemodynamic forces, an important factor limiting generali2ation of ouï resuits.
Venous pouches certainly differ from natarally occurring aneurysms, in dieir cellukr
composition but perhaps also in their biological reaction. The location of die
experimental aneurysm within die soft tissues of die canine neck also represents a
different microenvironment compared to die CSF space.
Other limitations include die small number of animais used and die absence of a long-
terni follow-up group. Finally, die stents used in diese experiments differ signfflcantly
from die seif-expandable stents in current clinical use.
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Conclusion
An addifional treatment, such as endoffielial denudafion, may improve ffie resi.ilts of
endovascular aneurysm treatment wiffi high porosity stents. More expenmental work is
needed to determine the optimal stent design to resuit in durable aneurysm occlusion
wbile preventing ischemic complications. A safe method to remove the endoffielium via
the endovascular route remains to be deveÏoped.
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TabLe f: Angiographic occlusion rates of aneurysms following endovascular stenting of ±e
parent ves sel with or wi±out aneurysm denudation.
Treatment
Dog Time Stenting Alone Stenting + Denudation
1 lOd Patent Patent
2 lCd Patent Occluded
3 10 w Occluded Occluded
4 10 w Patent Occluded
5 10 w Patent Occluded
6 10w Occluded Occluded
7 20 w Patent Occluded
8 20 w Patent Occluded
7/8 aneurysms freated with stenting and denudation completely occluded, compared to
2/8 aneurysms treated with stenting alone. (P = .040)
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Table 2: Stent-related branch occlusion and akered flow dynamic rates wiffi stenting
alone and with stenting and denudation.
Treatment
Stenting Alone Stentïng ÷ Denudation
p value
Occluded branches 2/32 (9%) 3/36 (7%) 1
Altered blood fiow 9/32 (26%) 8/36 (27%) .917
Figures
Figure 1: Endothelial denudation. Vein segments were stamed for Factor VIII,
showing endoffielial ceils (anow in (a)) when intact, but very few endoffielial ceils when
denuded (arrow in (b)). Original magnification 400x.
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Figure 2: Angiographic progression of experimentat aneurysms. Initial angiograms
at the urne of stenfing (a,c,e,g) are cornpared with 10 week follow-up angiograms (b,d,fh) using
the lingual (a-d) or carotid bifurcation aneurysm models (e-h) with (c,d,g,h) or without endotheliai
denudation (a,b,e,f). Note complete (d) or partial (h) occlusion when the aneurysm is denuded,
but large residual lesions when the endothelial lining was intact (b,f).
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Figure 3: Macroscopic photography. Typical resuits for aneurysms treated with
stentmg alone at 10 weeks are shown as ‘en-face’ views of aneurysm ostia, (a,b), and
sagittal sections through aneurysm remnants (c,d). Note the patent lingual artery ostium
in c) and the patent channel communicating with an open space within the aneurysm
fundus in d). ‘En-face’ views of aneurysm ostin treated wiffi stenting and denudation are
shown in e,f. Neointima formation over brandi vessels are shown in (g,h). Partially
occluded wide-neck carofld bifurcation aneurysm shown in 3(i) (CC: common carotid, LC
and RC: left and right carotid artenes; T: organized thrombus; R: residual aneurysm).
LCçr
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Figure 4: Immunopathology. Microphotographs of secfioned aneurysm treated with
stenting alone following immunohistochemical staining for smooth muscle actin (a) and
with GSL-1 for endothehal ceils (b). In b), brown-stained endothelial ceils hne a channel
extending from the neck to aneurysm fundus (arrows). Magnification a: 70X and b: 350X.
4.2 Effects of stenting the patent artery on aneurysm
fihting and gene exptession of various potentiat factors
invotved in heating of experimentat aneurysms
(Accepted in Interventional Neuroradiology)
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My contribution to the article entatled: Effects of Stenting die Parent Artery on Aneurysm
Filling and Gene Expression of Vaiious Potenflal Factors Involved in Healing of
Experimental Aneurysms consisted of planning and executing die experiments, as well as
writing die manuscnpt. During titis process, I originally beneflted from die assistance of
Igor Salazkin for die surgical creaflon of die carofld artery aneurysms, although I leamed
to create them independendy. Dr. Salazkin also assisted me wiffi die macroscopic and
microscopic photography of die aneurvsm/stent complexes and histology shdes. I was
taught to perform angiography and endovascular procedures on die animals, taking over
die procedures as die experiments progressed. I also leamed to perform necropsies and
designed a protocol for rapid tissue harvesting under anaesdiesia. I was taught to perform
die RNA extraction and RT-PCR procedures as well as die gel separaflon of die DNA. I
organized, prepared, and interpreted die angiographic, pathologic, and mRNA expression
data, with die assistance of Christelle Ogoudikpe. I beneflted from die assistance of
Fatiha Bouaeghrane for die iirimunohistochemistry of die aneurysm samples. Guylaine
Gevry assisted with die formatting of images and text for online submission. Staflsflcal
analysis was done by a dedicated biostaflsflcian, Miguel Chagnon. Finally, Jean Raymond
provided cnflcal review of die manusctipt.
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Abstract
Background and Purpose — Intracranial stents are increasingly used in the endovascular
treatment of aneurysms, but very littie is known regarding their effect on the cellular and molecular
evolution of aneurysms.
Methods — Bilateral venous pouch lateral wall carotid aneurysms were created in 20 dogs. Ail
dogs then underwent angiography and balloon-expandable stenting of one aneurysm 4 to 6 weeks
later. Fifteen dogs underwent aneurysm harvesting at I day (n=3), 4 days (n4), 7 days (n=3), and
14 days (n5) for mRNA expression analysis, using axial sections taken from the aneurysm neck
and fundus for RT-PCR amplification of four cytokines or growth factors: TNF-cç TGf-pl,
MCP-1, and PDGF-BB; two adhesion molecules: VCAM-1 and PECAM-1; five matrix modifyring
agents; IVilvfP-2, 9, TIIVIPs 1, 3, 4, and two cellular markers: CD34 and c-SMA. Five offier dogs,
sacrificed at 12 weeks, were examined for extent of fiuling of the aneurysm neck with organized
tissue and for neointima fomiation at the aneurysm ostium. Angiography was performed pdor to
sacrifice in ail animais, and compared with initial studies.
Resu fts — Eleven of 20 stented aneurysms showed a favorable angiographie evolution, while none
of the 20 non-stented aneurysms improved (p=0.001). Pathology showed partiaily occluded
aneurysms, with neointima formation around the stent struts. Observed trends in mRNA
expression, that stenting increased expression of genes involved in organization and neointima
formation, agreed with experimental hypoffieses, but differences between stented and non-stented
aneurysms did not reach statistical significance.
Conclusion — Parent vessel stenting was assodated with angiographic improvement of aneurysm
appearance. Modifications in mRNA expression pattems following stenting deserve ftirther smdy
to better establish potential molecular targets to promote aneurysm healing.
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Introduction
Endovascular coiling of intracranial aneurysms is increasing in popularity following the publication
of die resuits of die ISAT[1], but titis technique is too often associated with recurrences[2].
Attempts to decrease recurrences have tnggered die development of several technical and
bioengineering innovations [3-7], including endoluminal stenting. Currendy, stents are most often
used as an adjunct to coiling, but stents by diemselves have been reported to lead to aneurysm
occlusion[8-1O]. Beyond preventing coil herniation, die benefidal effects of stents are likely
realized by modifying fiow; they modify intra-aneurysmal hemodynamics, may provoke aneurysm
thrombosis, re-establish normal blood fiow pattems within the parent vessel, and perhaps buffer
die hemodynamic forces implicated in recurrences[11-15]. In addition, die stent may provide a
supporfive scaffold for neointima deposition at die junction of die parent vessel and aneurysm
neck.
The feasibffity of treating expeiimental aneurysms widi stents has been established using
angiographic and padiologic smdies[16, 17], but molectilar dues accounfing for die variable
treatment outcomes remain elusive. Conceptual and molecular parallels likely exist between i)
vascular wound healing, organi2ation and neoiniima formation within die body and neck of die
aneurysm[18]; ii) angiogenesis and recanalization at die aneurysm neck[19-21]; and iii) molecular
effects of fiow modification previously associated widi adieroma or stenting[13, 14].
For neointima and organization to completely £11 die defect formed by an aneurysm, die
provisional matrix formed by fibrin and platelets must be invaded and replaced by neointimal ceils
or myofibroblasts and secreted extracellular mattix[18]. In balloon-injury modeÏs, die process
resulting in neointima formation relies on complex signaEng cascades and cellular proliferation,
establishment of ceil-ceil and cell-mainx connections, and matrix degradation and reformation
[22]. At die aneurysm neck, anodier condition for stable occlusion is die absence of recanalizing
channels within die thrombus[19-21]. By altering fiow widi a stent, we aim to observe changes in
genetic ex-pression of key factors potendally involved in neointima formation/thrombus
organization or recana]ization.
11e genes diat we chose to follow can be classified into growth factors and cytokines (PDGF-BB,
TGF-1, INF-cc, MCP-1), adhesion molecules (integrin ccVf3III, VCAM-1, PECAM-1), matrix
metalloproteinases and dieir inhibitors QVIIVfP-2 and 9, and TTMP 1, 3, and 4), and die cellular
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marker c-SMA. To study the process of formation of recanalizing channels, we focused on the
expression CD34, as well as MCP-1 and die vfiVtPs / TIMPs.
Determination of gene expression changes that are assodated with favourable angiographic and
padiological resuits promises to usher in a new era of molecular-based aneurysm treatment, and
stenting offers a unique opportunity ta smdy die mechano-sensitive changes in mRNA expression
occurring within an aneurvsm following endovascular dierapy.
Materials and Methods
Protocols were approved by die Institutional Animal Care Committee in accordance with die
guidelines of die Canadian Coundi on Animal Care. Ail procedures were performed under general
anaesdiesia. Twenty beagles weighing 8-12 kg were sedated widi acepromazine (0.1 mg/kgi,
glycopyrralate (0.01 mg/kg), and butorphanol (0.1 mg/kgi, and anaesthesetized with intravenous
thiopental (15 mg/kg). Animais were ventilated ardficially and maintained under anaesthesia with
2% isoflurane. Post-operative analgesia was provided for three days widi a 50 ig Fentanyl patch.
We used die laterai wall carotid aneurysm model of German and Black, as modified by Graves [20,
23]. Briefly, die carotid arterv was accessed dirough a midiline incision. A portion of die lefi
extemal jugular vein was harvested and divided in haif ta form venous pouches. Temporary
aneurysm clips were applied to die proximal and distal carotid, and a 6 mm arteriotomy was
created. The vein pouch was attached ta die artery via an end-to-side anastomosis with mnning
7.0 Prolene suture, die apex of die pouches sealed widi hemostatic clips, and circulation restored.
After a 4-6 week period ta permit post-surgical changes ta abate, die endovascular procedure
performed. Following transfemorai angiography, a coronary balloon-expandable stent ranging in
length from 13-23 mm and in diameter from 3.0-4.5 mm was positioned to bridge one aneurysm
neck and deployed. The contralateral side subsequently underwent ba]loon angioplasty using die
same bailoon used ta expand die stent. Animais did not receive any antiplatelet agents or
anticoagulants. Angiography vas repeated immediately following stenting and piror ta sacrifice.
Fifteen animais underwent a separate harvesting pracedure at 1 day (n=3), 4 days (n=4), 7 days
(n=3) and 14 days (n=5) past-stenting, where die portions of die carotid artenes bearing die
aneurysms were removed under anaesdiesia. Animais were sacrificed by barbiturate overdose. An
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additional 5 dogs were sacnficed at 12 weeks for pathological analysis; their aneurysms were
removed and flxed in formalin.
The evolution of aneurysms following treatrnent was evaluated by examining the angiographic
progression between initial and final angiograms. A binary score of better versus same/worse was
given, based on whether the final aneurysm opadfled less, equal to or greater than on the initial
angiogram following stenting.
Pathological spedmens were prepared by cutting the stent/artery complex longitudinally, followed
by “en face” photography of the aneurysm ostium (Clemex, Quebec, Canada). Paffiological
flndings were studied afier formalin fixation and hematoxylin-phioxine-saffron (HPS), Movat’s
pentachrome, and immunohistochemical staining.
The fifteen animals analyzed for mRNA expression had each aneurysm cut at the junction wi± the
parent carotid, talting care flot to include carotid tissue. 2 mm and 3 mm axial sections of the
aneurysm neck and fimdus, respectively, were harvested (Figure 1). The tissue samples included
the vein pouch aneurysm wafl as well as any formed thrombus or tissue adherent to the wall.
Samples were frozen wi± liquid nitrogen. Isolation of total cellular RNA vas performed using the
phenol method. Aliquots of 1 to 3 pg were used for Erst strand cDNA synthesïs using Superscript
II reverse transcriptase (Invitrogen, Canada) and PCR amplifications were performed with
Platinum Taq polymerase (Invitrogen). After determining the linear range for each target gene,
amplification of the gene under study was carried out using the primers sequences listed in Table 1.
Thermal cycling conditions consisted of enzyme activation at 94°C for 1 minute, then a cycle of
denaturation also at 94°C for 1 minute, annealing as described in Table 1 and extension at 72°C,
each for I minute, repeated 40 times and 35 times for GAPDH. This was followed by a final
extension at 72°C for I minute. PCR products were separated on a l.5% agarose gel and stained
wi± ethidium bromide and LIV transifiumination. Quantitative analysis was carried out using a
computerized densitometric imager (ImageQuant; Amersham Biosciences, Canada) to obtain
gene/GAPDH ratios and thus correct for the variable amounts of tissue within the spedmens.
For each gene, the mean mRNA expression of the 14 genes at the 4 different time points was
quantifled for the neck and fundus of each stented aneurysm, and compared to that from the
corresponding control aneulysm.
Statistics:
Angiographie resuits were divided into two groups: a) decreased opacification b) unchanged or
increased size. These groups were compared wi± the McNemar two-tailed test. mRNA
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expression results were treated with ANOVA repeated measurements for three factors: stent, time,
and location (neck or fundus), using ±e Procedure Mixed program of SAS software, version 9. P
<0.05 was considered to be significant for ail tests.
Resu Its
A) Surgical and Endovascutar resuits:
Ail animais tolerated the surgical and endovascular procedures weil. Stent placement was deemed
adequate in ail cases, and resulted in an immediate increase in blood transit time tbrough the
aneurysm, as qualitatively assessed by the observer.
1. Angiographic resutts:
0f 40 aneurysms created in 20 dogs, 37 were patent at initial angiography at 4-6 weeks, for a
spontaneous occlusion rate of 7.S%. Stent deployment had an effect on angiographic progression
(Figure 2); 11 of 20 stented aneurysms were angiographicaily better, wbile none of the control
aneurysms improved (p=O.00I). Only one of the stented aneurysms became completely
obilterated on angiography at 12 weeks.
2. PathoLogy resuLts:
Macroscopically, stenting seemed to redefine the endoluminal boundary, with neointima formation
up to and around the stent struts at least in some cases (11/20) (Figure 3). In other cases (9/20),
stented aneurysms remained widely patent. Intermediate cases of incompletely occluded
aneurysms showed smafl channels connecting the parent vessel with dilated openings within the
organ2ing intra-aneurysmal thrombus. Non-stented control aneurysms were usually widely
patent, while some had partial fl]Eng of the flmdus wiffi organized tissue.
B) mRNA expression resutts
RT-PCR resuits in stented and control aneurysms are fflustrated in figure 4 and summarized in
table 2.
1. Growth factors and cytokines:
The kinetic profile of TGF-r31 expression at the aneurysm neck showed an initial decrease,
reaching a nadir at 4 days, with a subsequent slow continuous increase in expression to 14 days,
with only slightly greater expression for stented aneurysms compared to non-stented aneurysms.
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TGF-1 expression in the tissue from the fundus was remarkably similar between stented and
non-stented aneurysms. Both showed a decrease similar to diat of the tissue from the neck, wi± a
more delayed nadir at 7 days.
PDGF-BB expression of neck tissue for stented aneurysms remained fairly constant for 7 days,
foilowed by an increase at 14 days. During tins interval, non-stented neck expression of PDGF
BB decreased until the 7 day mark, and dien increased to 14 days. M the level of die aneurysm
fl.indus, stented aneurysms showed a small decrease until 7 days, with subsequent increase. Non
stented aneurysms showed a smafl increase, peaking at 4 days and then tapering off.
The peak expression at of TNF-Œ at 4 days is compatible with inflammatory ceil infiltration and
secretion. We observed almost parallel TNF-c expression cunres for bodi stented and non-stented
controls at the neck and fundus. Stented ftmdus showed a slighdy higher peak at 4 days and a
deeper nadir at 7 days than controls.
MCP-1 expression at the neck was lower for stented aneurysms at ail time points compared to
controls. At the flmdus, the stent led to decreased MCP-1 expression compared to controls over
die flrst 7 days, which slowly increased to become greater than controls at 14 days.
The differences in mRNA expression between stented and non-stented aneurysms were not
statistically significant for any growth factors or cytokines assayed at either die neck or die fundus.
2. Adhesion motecutes:
PECAM-1 expression was variable at die different dine-points, showing a biphasic increasing
pattem for neck tissue stented aneurysms, widi a small peak at 4 days, wbile non-stented tissue at
die neck and stented and non-stented flindus tissue ail showed sharply decreasing expression
initially diat subsequendy tapered off at 14 days.
We observed only smail increases in VCAM-1 expression for stented aneurysms at die neck and
fundus over die flrst 7 days, winch subsequendy norma]ized. Non-stented neck and fundus tissue
expressed more VCAM-1 dian stented tissue over die flrst 7 days; tins trend was reversed for days
7-14.
We found diat integrin ccvI expression of neck tissue steadily increased from I day to 7 days,
foilowed by a return to low levels of expression at 14 days. During tins interval, die expression of
integrin OEvI of non-stented control necks increased rapidly, peaking at 4 days, and dien rapidly
dropped to baseline by 7 days, remaining at low levels. For bodi stented and non-stented fundus
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tissue, a very mild mcrease in expression occurred over the Erst 7 days, followed by a slow retum
to baseline by 14 days.
None of the difference in changes in mRNA expression between stented and non-stented controls
were statistically significant for any adhesion molecules.
3. MMPs / TIMPs:
IvUVIP-2 expression at the neck of stented aneurysms increased to a peak at 4 days and remained
elevated, gendy decreasing to 14 days. Non-stented neck tissue showed a steady, continuous
decrease in IVIIVIP-2 expression from day I to day 14. The curves for Ivil’viP-2 expression at the
fundus were very similar between stented and non-stented groups, with a slight predominance in
stented IV11\{P-2 expression beginning on day 4 and confinuing until day 14.
IvilvfP-9 expression of stented neck tissue increased sharply at 4 days and quickly returned to
baseline. Non-stented control neck tissue, as weil as fundus tissue from stented and non-stented
aneurysms remained at a low level of IvllVfP-9 expression across ail time points.
TTIvW-1 expression cunres were almost parailel for stented and non-stented groups at die neck and
ftindus. Ex-pression decreased rapidlly over the flrst 7 days, followed by a recovery at 14 days.
TIMP-1 expression was slighdy less for stented necks compared to ail other groups.
TEvW-3 expression increased for ail groups to a smail peak at 4 days, followed by a decrease to
baseline by 7 days, remaining at this low level until 14 days. TIIvIP-3 expression was slighdy less
for stented necks compared to ail odier groups.
TTIvIP-4 expression profiles were almost parallel for bodi stented and non-stented necks, with
expression levels slighfly lower for stented necks. At the fundus, TIIVfP-4 expression levels of
stented and non-stented aneurysms were mirror images of each other; stented tissue decreased at 4
days, followed by a peak at 7 days with a retum to baseline by 14 days, wbile non-stented fundus
tissue peaked at 4 days, dropped at 7 days, and then became elevated again at 14 days.
The differences in mRNA expression between stented and non-stented controls were flot
statisticaily significant for any of die MIVWs or TIIVWs.
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4. CeltuLar markers:
Neck tissue from stented aneurysms showed a steady increase in czt-SMA expression over ifie flrst 4
days, winch then leveled off. Œ-SMA expression of non-stented necks was lower than for stented
necks for ail tinte points except at one day, a time-point for winch we had difflculty with mRNA
degradation and sample loss. Tissue at the flmdus also showed an overail decrease in Œ-SMA
expression for stented and non-stented controls without clear differences in expression profiles.
Both stented and non-stented aneurysm necks showed increasing CD34 expression, reaching the
same peak at 4 days, with subsequent slow return to baseline over 14 days. Non-stented fimdus
tissue did flot show die same peak at 4 days, remaining at a level of expression doser to baseline.
The difference in -SMA or CD34 mRNA expression between stented and non-stented
aneurysms was not stadstically signifiant for tissue from either die aneurysm neck or ffindus.
Discussion
The salient flndings from tins work are tint stents improve die angiograpinc and pathologic
appearance of lateral wall aneurysms in 55% of cases, and that tins improvement correlated with
several mRNA expression trends of genes implicated in neointima formation and thrombus
organization: i) increased expression of the growth factors TGF-1 and PDGF-BB for aneurysm
neck tissue starting at 4 days; ii) decreased expression of the pro-inflammatory and chemotactic
agents TNF-Œ and MCP-1, and iii) increased expression of IVIIVW-2 and IvilvW-9 at die aneurysm
flmdus, as well as decreased TTIvW-1, 3, and 4 at the aneurysm neck. The improved neointima
formation was further reflected in a trend towards increased a-SMA expression of tissue from die
neck of stented aneurysms. There were no observed trends in mRNA expression of PECAM-1,
VCAM-1, or integrin cv to suggest a role for adhesion molecules to account for the ftnproved
appearance of stented aneurysms.
The contribution of stenting to aneurysm healing is difflcult to assess when stents are used as
adjuncts to coffing. The obsewed angiograpinc improvement following stenting suggests that their
role in aneurysm healing may extend beyond prevention of coil hemiation; we hypothesized diat
tins effect was at least in part mediated by flow dismption wiffi subsequent changes in genetic
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expression. Hypothetical stent-related modifications of gene expression are summarized in Table
9
TGF-pl is a multifunctional regulator; its actions are dependent on species, ceil phenotype, growth
conditions, and interaction with other growth factors [24, 25]. In affierosclerosis, with disrupted
blood fiow pattems, TGF-l promotes lesion formation and vascular smooth muscle ce11 (VSMC)
proliferation[26, 27]. Alterations in shear stress can upregulate TGF-f31 expression[28], and we
were able to detect a non-significant increase in TGF-31 expression at die aneurysm neck
following stenting, which may provide a molecular explanafion for die increased neointima
formation observed at pathology.
PDGF-BB is a potent chemoattractant and mitogen produced by activated platelets and
macrophages diat stimulates VSMC proliferation and migration[22]. Expedments that surgically
decreased blood flow in an animal model increased PDGf-BB expression [29]. Cultured
endothelial cefis increased PDGF-BR expression in response to increased shear stress and
turbulent blood flow [30]. The marginal increase in PDGF-BB expression in stented aneurysm
neck and fundus tissue beginning afrer 7 days may have contributed to increased neointimal
formation.
The pro-inflammatory effects of TNF- are well-characterized[31-33]. This cytokine is produced
by macrophages, neutrophils, endothelial ceils and VSMCs, and exerts multiple biological effects
on a multitude of ceil types [31, 33]. TNF- locaily augments die expression of adhesion
molecules and MCP-1 and attracts leukocytes. TNF-Œ also modulates growth factor expression,
stimulates IvllvW acfivity, and can trigger endotheial ceil apoptosis [33, 34]. TNF-ac has been
implicated in die generaiion of adierosclerotic lesions at site of turbulent blood ftow; laminar
blood fiow inhibits TNF-c expression[32], whereas adieromatous areas characterized by turbulent
blood flow have high TNF-c levels [35J. Recause stents disturb blood fiow, we had expected
stenting to increase TNF-c expression, and for dis to inŒease expression of adhesion molecules.
We did not however observe expression changes ofTNF- or adhesion molecules.
MCP-1 is implicated in de formation of atherosclerotic lesions [36], neointimal hyperpiasia
following bailoon injury[37, 38], and may also play a role in de recana]ization of organi2ed
intravascular tbrombi [21]. Laminar flow inhibits MCP-1 expression [39], and we had anticipated
that fiow dismption due to stenting would increase MCP-1 expression. As with TNF-cç
observed a trend towards lower expression levels of MCP-l for stented aneurysms at ail time
points compared to controls. Changes in MCP-1 expression are known to occur ultra-early
(within 5 hours) in cultured endothelial cells[40], and so it js possible that die time-points we chose
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may have missed important early events. NonetheÏess, because MCP-1 is also imphcated in
promoting the recanalization of organized thrombus (and thus potentially, recurrences), a relative
decrease in expression of this chemokine may prove beneficial.
The balance of IvilvtP and TIMP activity is essential to maintain the proper ‘fluidity’ of the
extracellular mattix[41]. The activity of the collagenases MMP-2 and MIVIP-9 is thought to be
essential to permit cellular migration [25] of neointimal ceils into the provisïonal matrix of platelets
and fibrin within a treated aneurysm. MlvlPs are also essential to the process of angiogenesis[42],
and contnbute to the formation of neovessels witbin organizing thrombi. A strategy to decrease
the incidence of aneurysm recurrences due to the formation of recanalizing channels or neovessels
connected to the parent vessel could aim to inhibit IvilvfP or promote TIIvW activity. Proper
timing of intervention would be necessary to ensure that suffident neointimal ceils had migrated
into die provisional matrix prior to form a robust neointima prior to altering the balance of
IVII’vW/TTIVW activity to minimize the formation of recanalizing neovessels.
IvilvfPs can also modulate signal transduction pathways by acting on inflamrnatory mediators,
growth factors, and growth factor receptors [43]. IVilvIP-2 and MMP-9 production and activation
are increased following arterial balloon injury and subsequent remodeling [44, 45], and IvfMP-9 has
been localized to atheroscleroiac plaques in humans[46]. In an in vitro model, elevated shear stress
induces changes in IvflvtP-2 and MNW-9 expression diat follow different temporal pattems: two
days after shear onset, IvIIvIP-2 expression levels increase and remain elevated, while IVflVil’-9 peaks
quicldy and decreases [25]. IVilVfP-9 expression is also responsive to shear pattem, with osdulatory
or turbulent blood flow resulting in greater, more sustained expression compared to unidirectional
shear [47]. We anticipated that the flow disturbances caused by stenting would increase expression
of both IVIIVIPs, widi a more sustained elevation for MIvfP-2 than IvllvfP-9. We further anticipated
a decrease in TII\’W activity to resuit in a net decrease in die MIvfP/TIIvW balance.
We observed only small increases in IVIMP-2 activity in the necks and fiindi of stented aneurysm
compared to controls, which started after 4 days. Because MIVIPs are potent enzymes, perhaps
only small changes in lVllvW expression, in conjunction with the observed decreased TIIVW
expression may be sufficient to lead to matrix degradation and allow greater neointimal cdl
migration and promote aneurysm healing. The sharp, transient increase in Iv[MP-9 expression at 4
days for stented neck tissue was in agreement with published findings, and may reflect die
increased exposure of ceils of die aneurysm neck to die mechanical force of blood flow.
The Œ-SMA ceils were antidpated to follow die pattem of migration observed in arterial balloon
injury models, where ceils begin to proliferate in die media afrer approximately 24 hours [48], then
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migrate into die intima at 4 days, continue to proliferate and form extracellular mainx for at least 3
months [49]. In our experiment, we hypothesized that the stent would provoke thrombosis within
die aneurysm, and die ex-pression of Œ-SMA would increase as die ceils that coninbute ta
neointima formation populate die provisional matrix formed within tEe thrombosed aneurysm.
With die exception of die time-point at 1 day, die kinetic profile of Œ-SMA ex-pression for stented
tissue at die neck was in accordance with expectations far progressive thrombus invasion with
ceils destined ta populate and from die neointima. The presence of diese ceils is likely of
particular importance at die neck af endovascularly treated aneurysms, ta promote robust
neointima formation at die junction of die parent vesse1 and aneurysm neck.
As observed with die resolution of deep venous thrombi, die process af recanalization within and
around die formed intra-aneurysmal thrombus may contribute to aneurysm recurrences. Ta
investigate die molecular aspects of this process, we followed expression levels of MCP-1,
IvfMPs/TllvWs, and CD34. The chemokine MCP-1 has recendy been implicated to stimulate die
monacyuc ddEng of ‘tunnels’ within thrombi [50j, and die uniformly lower expression of MCP-l
of stented aneurysm neck tissue may partiaily account for die better angiographic and pathologic
outcomes observed at 12 weeks.
There was no reliable means ta differentiate IvUVfP or TflvfP activity needed for neointimal cell
migration from diat of neovessel formation. By observing die kinetics of TIMP expression
following aneurysm treatment, die initial decrease in expression lasted 7 days before increasing
again; perhaps this petiod of dine is sufficient to allow for neaintimai ceil migration, and future
pharmacologic interventions ta alter die MIvIP/TIIvIP balance to prevent recurrences might be
timed for 7 days post-stenting.
CD34 expression was assayed ta search for a possible increase in ceils of endodielial lineage within
die aneurysmal thrombus, particularly at die neck. Neovessels prapagating through die thrombus
could originate from die tissues surrounding die aneurysm aiming to provide blood supply ta die
neointimal ceils; altematively, they could represent nefariaus recanalizing channels adginating fram
die parent vessel. Circulating endadielial progenitor ceils may also contribute to die observed
CD34 expression. The CD34 expression profiles af stented and non-stented aneurysms did not
clarify die role of recanalizatian in aneurysm recurrences in this experimental madel.
The greatest limitation of this experiment was die smail number of dogs we used. As with ail
animal experimentation, we are limited by ethical and practacal considerations; given die sire af tEe
effects we observed here, perhaps 50 or more animais would have been needed ta attain stafistical
significance, a sacrifice we could not justify given die lack of indicafions of where potentiafly
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ndings were. Other sources of variation of our model include the variabffity of posidoning of the
stent struts relative to the aneurysm ostium, which may have resulted in inconsistent modulation
of the fluid dynamics and relatively large changes in mRNA expression. Akhough we corrected
for cellularity by using GAPDH:gene ratios, vatiability in the formation of thrombus within the
aneurysmal pouch may have affected the mRNA expression resuits. More refined molecular tools
also remain to be developed for use in the canine model. Altematively, we may have omitted
some key molecular factors that change dramatically in response to mechanical forces, or our
window of samphng may have missed important ultra-early or late events. The cellular
composition of a venous pouch aneuiysm is different from that of a naturally occurring aneurysm,
and the local environment of the experimental aneurysms certainly differed from subarachnoid
aneurysms. Finally, balloon-expendable coronary stents are not alike currently available self
expendable intracranial stents.
Conclusions
Parent vesse1 stendng is insufficient to cause complete occlusion of lateral wall aneurysms when
used alone. However, stenting does contribute to the healing process, as evidenced by the
improvement in angiographic and pathologic appearance in 55% of cases. We were unable to
detect statisflcally significant stent-related differences in mRNA expression, although we observed
trends in expression of growth factors, cytokines, and matrix agents that may prove useful to the
friture design of a molecular-based therapy for aneurysms.
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Table 1. Sequences of primers of selected genes chosen for RT-PCR.
Gin. Tm NT(bp) Fowud pdnwr R.ei pilm.r
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markers CD-3I 52 667 5-CCCA000TOACACTGGACM-Y
GO-34 64 434 5’-GCCCAGTCTGAGGTGAOGCCTCA-Y
84 622 5’-GTCAÂGGAGGAflCAOCAUGAT-3’
VCAM 58 694 5’-CTCflGGAGAACCCAGATAGACAGTC-3’
Reporter GAPDH 64 500 5-GCCWA000TCATCATCTC-Y
MMPs MMP-2 56 560 5-ATGCAGA60HCm000CTGC-3’
MMP-9 64 476 5’-TATGACACCGACCGTCGGflC-Y
TIMPs TIMP-1 52 341 5-GCGHATGÂGATCAAGATGAC-3’
TIMP-3 52 260 5-TACCAGTACCTOCTGACAGG-3
TIMP4 58 331 5’-ATCTCCAGTGAGPAGGTAGT-3
Gmwth TGF1 64 366 5’-UCCTGCTCCTCATGOCCAC-Y
Factor POGFOS 64 393 5’-ATGAAT000TGCT000CGGTCflCCT-3
TNFs M 436 6’-CCTCC6ACTAATCA000CTCT-3
MCPI M 305 5-ATGMGGTCTCCGCAGCGCTC-3
5-CCUCTGGATGGTGAAGflGG3 Consensus humanlmloe
5’-CAGGTGUGTCU0CTGMTGG-3 Ong (14M 0010633411)
n-AGCAGCMrrGCAATATCAnGA-Y Consensus humanlrt4ce
5-ATGUCCAGAÂTCflCCAGCCTCATAGCAAflAY Ong )NM 001003268.1)
5’-GCCCATCCACAGTCUCT-3 Consensus humsnlmlcc
5-UGCCATCCUCTCMAGflGTA-3 Ong (AF 177217)
5-GTACATGAGCGCflCTOOCAC-Y Ong (AF 1692M)
5’-CTGGTCCGTCCACMGCA-Y Oog (14M 001003182.1)
5’-GCCCATCCTCGGTACCAGCT-3’ Ong )XM 63840.2)
5-GTGGTGA1TFGGCAGCCACAGUC-3 Consensus humaivmiœ
5’-GCAGGAGCGCACGATCATGT-Y Ong (6M 001063369)
5’-GGAGCAGCGGTGCACCTCCAC-3 Dng (14M-001003383)
5-TCTCAGCGCTGAGTCGATCA-3 Ong (NM 001003244.1)
5-TCATGGCTrrGCAGm0001TFG-3 Consensus humanImce
Type
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Table 2. Genes potentially involved in the molecular mechanisms of aneuiysm healing, with
the hypothesized expression changes obtained from a survey of the literature of other vascular
processes, and our experimental observations.
Expression Changes due to Stent
GENE Hypothesized Observed
TGF-Ç t t
PDGF-BB t t
MCP-1 t
TNF-a t
VCAM-1 t -
MMP-2 t t
MMP-9 t t
TIMP-1 4.
TIMP-3
TIMP-4
10$
Figures
Figure 1. Schematic of tissue chosen for mRNA expression studies: 2 and 3mm axial
sections of aneurysm tissue, from the neck and fundus, respectively, were harvested.
Figure 2. Angiographic progression of stented lateral wall aneurysms with time. A, C)
represent initial images at 4-6 weeks following surgical creation. B, D) show improved
angiographie appearance following stenting, but flot complete obliteration, at 4 days aix) 12
weeks respectively.
1.
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Figure 3. Photographs of stented (A-D) and non-stented (E-F) control aneurysms. Good
neointima formation in (A, B), fihling aneuiysm body and neck and incorporating stent struts.
C, D) reveal incomplete neointimal fihling, with the aneurismal defect evident on en-face as
well as sagittal views. E, F) demonstration the widely patent ostia and minimal neointimal
fihling typical of non-stented control aneuiysms.
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Figure 4. Gene expression associated with stenting. Resuits of RT-PCR analyses, expressed
as specimen!arterial controls ratio, according to time. A) Gene expression at the fundus B)
Gene expression at the neck of aneuiysms. (.= Stented; o Not stented).
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5. DISCUSSION
The primary goal of therapy for intracranial aneurysms is usually to prevent future
aneurysm rupture. Clinically, digital subtraction angiography is considered ffie best
surrogate outcome to assess for nsk of future rupture and ffius evaluate aneurysm
tieatments. Wbile angiography remains ffie best clinlcally available measure of aneurysm
treatment, it cannot reliably distinguish those aneurysms destined to remam occluded
from aneurysms likely to recur. However, smdies of expedmental aneurysms demonstrate
associations between type of aneurysm txeatment and pathological outcomes, and have
identifled features associated wiffi durable aneurysm occlusion[93j. Autopsy specimens of
healed human aneurysms after embolization are few, but ndings suggest that stable
angiographic resuks are associated with neoiniima formation at the neck, without
recanaliamg crescents[1961. Molecular biology may hold the key to understanding the
causal hnks leading to these variable pathological outcomes. Insight mto the molecular
mechanisms of thrombus formation, cellular invasion, ffirombus organization and
neoindma formation may lead to therapies to closely control the amount of tissue formed
witbin treated aneurysms; complete fihling of die aneurysm body and neck may promote
more durable resuks. Further characterizaflon of the role of endoffielial ceils in the
treatment response, as well as the kinetics and mechamcs of re-endoffielializatton and
thrombus recanalization may reveal new targets for molecular-based aneurysm treatment
strategies.
The molecular processes occurring in the area of the aneurysm following endovascular
treatment are very complex, and remain poody understood. In the absence of established
knowledge regarding die molecular mechamsms of aneurysm healing, research into this
nascent fleld relies on established literature from offier domains. The arrivai and
formation of ceils and extracellular matrix within the body of the aneurysm and the
formation of a mural structure at the neck may resemble die events occurnng following
bafloon-angioplasty injury with neoindmai hyperpiasia, while the flow-related genetic
modifications due to stenting may mimic those known to occur in affierosclerosis. The
invasion of the matrix within die aneurysm wiffi ceils seeldng to vascularize this newly
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formed tissue may share conceptual similaiities wiffi angiogenesis. Finally, the DVT
recanalization process known to restore blood flow past occluded veins may also act on
iatrogenically formed intra-aneuiysmal thrombi. The molecular biology portion of this
work relies on the principle of parsimony of natare; we only stand to make discoveries if
considerable molecular similarities exist between aneurysm heahng and other known
vascular phenomena.
Research using expenmental aneurysms permits us to seek the biochemical or molecular
mechanisms that lie behind obsewed padiological phenomena. Virchow’s fflad inspired
our search for modifiable factors possibly mvolved in aneurysm healing; endothelial
denudation as a form of controlled trauma to die blood vessel and endoluminal stenting
as a means to modify flow and promote intra-aneurysmal stasis were the manifestations of
this inspiration. We also aimed to capitalize on the fact that stent placement within die
parent artery allows us to harvest aneurysm tissue wiffiout artifacts caused by metal coils.
Another advantage of using stents to smdy genetic effects of flow modification is that
stents hkely cause a more reproducible dismption in flow compared to endosaccular coils.
In die spint of Virchow, I will begin by focusing on die paffiophysiological processes of
intra-aneurysmal neointima formation/thrombus organization and recanalization,
followed by a discussion of die potential role of endodielial ceils. I will conclude with die
potential role of stents and flow dismption as a means to treat aneurysms.
5.1 NEOINTIMA FORMATION I THROMBUS ORGANIZATION
In an effort to maintam clarity of language regarding diese processes, some preamble is
necessary. The cellular events occurting within an endovascularly treated aneurysm
involve die formation and maturation of thrombus, spanning from die depffis of die
aneurysm fundus to die tbrombus nearest die aneurysm neck that is exposed to blood
flow. Traditionally, a distinction lias been made between die processes of dirombus
organization and neoiniima formation, wiffi die latter term reserved exclusively for a
vessel wali reaction to some type of injury. However, at die Ïevel of die aneurysm ostium
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diere is no vessel wall and die ‘neointima’ is synonymous wiffi ‘thrornbus organization’
occurring at the interface of die blood vessel and circulatrng blood flow. The largely
artificial distinction between what goes on inside the sac of die aneurysm and die ostium,
winch is a continuous process wiffiout clear-cut boundary in pathological specimens
(Figure 5.1), akhough important to classical padiological vascular paradigms, is hereafrer
disregarded; die process of cellular proliferafion, migration and extracellular matrix
production that occurs at blood-flow exposed regions is considered to represent die same
process diat occurs to full die substance of die aneurysrn. Morphological differences
remain, perceived as a specific orientation of ceils as we corne doser to die circulating
blood at die residual neck, but die distinction is here conceived as a nuance of die same
phenornenon.
FIGURE 5.1 Photomicrographs of axial sections tbrough an aneurysm.
The evolurion of die thrornbus fonried within die aneurysrn seems to be variable. In
some cases, following treatment, a robust pro’visional rnatrix is formed within aneurysrn,
followed by invasion of ceils destined to organize die tbrornbus and form neointima.
Sufficient extracellular rnatrix is deposited, and neovessels (or extensions from pre-existing
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vessels) develop to supply the newly formed intra-aneurysmal tissue. The parent vessel
then undergoes a penod of remodeling, resulting in a blood flow conduit that recreates
normal flow pattems and stably resumes a form that does flot include an aneurysmal
dilation. In other cases, the aneurysm does flot become completely obliterated. This
outcome resuits from either incomplete treatment, where die residual neck or saccular
remnant is immediately anglograpblCally apparent, or from aneurysm recunence following
treatment initially deemed angiographically complete. Compared to completely treated
aneurysmS, incompletely treated aneurysms are more hkely to recur[197, 19$j; this
detemiination has stimulated die use of packing density as a measure of the extent of
treatment, a well as die development of modified coils winch swell following deployment
and increase die volume of space lled by die coils[26J. However, structural-based
attempts to increase die volume of die aneurysm fllled by coils do flot address die
biological phenomena diat lead to recurrence of both incomplete and completely treated
aneurysms.
The formation of intra-aneurysmal thrombus is die sine qua non of aneurysm healing, as
the platelet and fibrin thrombus fonns an essential provisional matrix for subsequent
cellular invasion. The strength of adhesion of die fomied thrombus to the deposited coils
and wall of the aneurysm may impact die evolution of treatment. Alihough antiplatelet or
anticoagulation use following stenting is common in clinical practice, the more active
canine fibrinolytic system permits die use of stents widiout die same tisk of thrombotc
sequelae seen in humans.
The dissecting effects of blood flow may form channels into the thrombus/coil mass, an
effect winch seems particulady evident at the inflow zone of expenmental lateral wall
aneurysms. A layer of thrombus immediately apposed to the aneurysm wall may also
facilitate die invasion of ceils from adjacent tissues hito die provisional matrix 11ing the
body of the aneurysm. (Ihe presence of an intact endothelial layer may interfere with the
close apposition of these layers; die endothelium is discussed later on). Another potential
reason why flrm adhesions between the thrombus and aneurysm wall may be important is
diat die contractile forces of die x-smoodi muscle actm positive ceils within die maturing
thrombus tends to create a centripetal force coflapsing die aneurysm (see figure 1.6). Tins
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natural wound healing process helps minimize the dead-space ffiat must be lled by
healing ceils, but in the case of endovascularly treated aneurysms, the contractile force may
pull the thrombus away from the aneurysm wall and form fissures (Figure 5.2) that
subsequently develop into recurrences. The balance of matrix metalloproteinase acttvity at
the margins of the thrombus/aneurysm wall interface may also play a role in the strength
of adherence and the resistance to fissure formation.
FIGURE 5.2
Photograph of coronal section through
a lateral wall aneurysm.
The formation of neointima depends on adequate proliferation and migration of ceils into
the aneurysm body, replacing the provisional matdx with more permanent ECM proteins.
Cardiologists are greatly interested to discover ways to limit the formation of neointima
and prevent re-stenosis following balloon angioplasty and stenfing, and the literature is full
of examples of new drugs targeting the ceil cycle or nuclear signaling paffiways to limit the
proliferafion and migration of neointimal ceils. Endovascular treatments directed towards
aneurysms are interested in modulating neointima formation differently at two different
sites. First, we aim to pîvmote neointima formation at the aneurysm neck and organizanon
witbin the aneurysm body, to recreate an arterial blood fiow conduit without a
pathological dilation. By augmenting neointima formation, we hope to decrease die rate
of recunences from incompletely treated aneurysms. Increased neointimal thickness, at
least in animal models, lias been correlated with better hea]ing[25, 146, 199]. The second
site where neointima formation is of interest to us applies to endovascular strategies using
stents, where good neointima formation around the stent is required to incorporate the
stent into the wall and cover the potentially thrombogenic surface. 0f course, like die
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cardiologists, we are also concemed about over-exuberant neointima formation leading to
parent vessel stenosis or branch occlusion.
Our attempts to smdy die effects of flow modification on die genetic expression of key
molecules involved in aneurysm healing focused primarily on growth factors, cytokines,
adhesion molecules, and ceil surface markers potentially important to die process of
neointima formation, as well as die enzymes involved in regulating ceil migration through
die matrix. (We also looked at die expression of one ceil surface marker, CD34, to smdy
die progression of endodielialized channels witbin die treated aneurysm, winch will be
discussed ]ater.) The discovery of a growth factor able to locally stimulate neoinfima
formation within die aneurysm might permit modulation of aneurysm healing using
biologically coated coils. We were also seeking a molecular explanation for die observed
improved angiographic and padiologic resuks following stenting. Many of die factors we
studied had been shown to be responsive to flow in odier models of vascular disease, and
we did notice some interesting trends in mRNA expression changes following stenting,
even diough diese differences did flot reach statistical significance (see section 5.5.1 for
expenmental limitations). NonetheÏess, die trends suggest two things: First, die growth
factors and adhesion molecules we chose seem to play a role in die formation of
neointima and thrombus organization; second, diat diere is an increase in
endodielialization over time within the substance of the aneuysm. These flndings shed some
light on die molecular mechanisms of aneurysm healing, and also support a role for using
stents to improve die resuits of aneurysm treatment, even diough stenting did not lead to
die dramatic mRNA expression changes we originally expected.
Strategies ainiing to improve aneurysm healing by targetmg die action of MI\fPs or dieir
inhibitors present new exciting possibifities. These enzymes are potentially important to
two separate processes; die migration of ceils destmed to form neointima, as well as die
formation of new vascular channels within die organizing tissue. Strategies diat promote
matrix degradation to promote ceil migration must be viewed widi extzeme caution;
IVIIVTPs are potentially very destructive enzymes, and die potential consequences of
thinning die mattix around recendy treated aneurysms should not be underestimated. The
more interesting therapeufic goal of preventing MIvfP acdvity and inhibiting die formation
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of new vascular channels within the thrombus is further discussed in die following section
on recanalization.
5.2 RECANALIZATION
Recanalization is known to occur at the margins of deep venous thromboses[200, 201]. In
linear vessels occluded by thrombus, small neovessels attempt to form channels around
the tbrombus, to re-connect the patent portions of the vessel on each side and re-establish
blood flow. Recanalizaflon is also likely at work in the setting of endovascularly treated
aneurysms, originating from the aneurysm ostium and attempting to form channels
towards the fundus. Un]ike die situation of a thrombus separaling linear blood vessels,
however, the aneurysm remains a blind-ended pouch, and the process of recanalizatton
serves only to recreate anodier blind-ended channel winch may develop into anoffier
aneurysm. There are at least three factors winch likely promote recanalizanon of intra
aneurysmal thrombus: monocytic ‘tunnels’, increased matrix metalloproteinase acflvity,
and hemodynamic forces.
The recent discovery of MCP-1-dependent tunnel drilling by monocytes occurs witbin
intravascular tbrombus, in conjunction widi the discovery of circulating progemtor celis,
suggests a new mechamsm for thrombus recanalization[79, 94]. In tins scheme, die
monocytes diat coat die luminal surface of an intravascular dot form tiny crevices or
‘tunnels’ into die thrombus, into winch circulating celis may subsequenfly sertie and
differentiate. This possibly represents a mechanism for die creanon of die observed
neovessels implicated in aneurysm recanalization. By implicating monocytes and MCP-1
in die process, it also presents a possible therapeutic target to decrease recunence rates.
Anodier potential means to decrease die formation of neovessels through die thrombus
involves modulating die ratio of MMP/TIMP activity. Specific inhibition of MMPs has
been shown in models of angiogenesis to decrease die formation of capillary tubes[60], a
ffiiding winch has important implications for many vasculo-proliferafive processes,
including aneurysm recurrences. Selective inhibition of MIVWs involved in recanalizadon
(neovessel formation from die parent vessel) while permittmg matrix degradadon for
cellular migration and thrombus organizafion and preserving die formation of vessel
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supplymg neointima ceils is die goal of tins treatment strategy. This work focused on the
more modest goal of identifying MMP or TIMP family members potentially important to
these processes in aneurysms. Our observation of a transient sharp increase in MMP-9
expression with stentmg, although flot staflstically significant, may ment furdier
investigation.
Hemodynamic forces are implicated in the formation and rupture of aneurysms, and are
also known to affect die evolution of treated aneurysms[194, 202, 203J. Pulsatile blood
flow orients and directs the formation of neovessels in models of angiogenesis[60j, and
may stimulate die expansion and growdi of small channels into die maturing thrombus,
boffi by mechanical sepanadon and spreading of die organizing thrombus, as well as by
altedng cellulan signaling cascades of mechano-responsive ceils. figure 5.3 depicts die
decreased blood flow into a lateral wall aneurysm following stenting. One of die possible
beneficial effects of endovascular stentmg may be to buffer die hemodynamic forces
implicated in recurrences by absorbing and dispersing die pulsations of blood llow
through die stent structure. This buffering effect would be more pronounced widi more
nigid stents, potentially necessitating a trade-off for die increased ftexibffity anti intracranial
navigation of newer generafion stents. The abffity of a stent to absorb and disperse
hemodynamic forces also certainly depends on die magnitude of force acting on die
formed tbrombus.
FIGURE 5.3 Schematic showing die direction and attenuation of blood flow into a
lateral wall aneurysm.
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5.3 STENTS AND BLOOD FLOW MODIFICATION
The clinical use of intracranial stents for the treatment of aneurysms is stiil in ïts infancy.
There remain many unanswered questions, including: i) the optimal stent design to
provoke aneurysm thrombosis yet minirmze thrombotic tisks, both to the parent vessel
and perforating branches covered by die stent; il) the nature of the response of die parent
vessel and aneurysm to stenting, and how to control it; and iii) how flow alteration
impacts aneurvsm healing. Finally, and most importantly, given the higher recurrence
rates cunendy associated widi endovascular treatment, justifying the choice of
endovascular treatment over surgical cipping requires more thorough knowledge of the
risks associated with the various intravascular devices.
The optimal stent design that attains the therapeutic goals of provoking aneurysm
tbrombosis while sparing adjacent branches depends on die local microanatomy of the
targeted aneurysm. More basic research is required to understand die effect of different
stent ceil pattems on blood flow disrupfion. In die future, stents designed and oriented to
conform perfectly to die parent artery with a high density mesh over die aneurysm ostium
and openings to permit unobstmcted blood flow into brandi vessels may be
manufactured according to specificattons and measurements taken from an angiogram,
personalizing die structural component of die stent to meet the therapeutic goals. As we
progress into a new era of DNA mapping, the biological agents used to coat endovascular
devices may also take into account the patient’s genome and proteome to promote stable
aneurysm occlusion and minimize in-stent stenosis. Advances in molecular biology may
one day allow us to engage in prevenuve medicine directed against aneurysm formation
and reduce the prevalence of aneurysms and incidence of SAH. In the meantime, we will
continue to attempt to charactenze die molecular and cellular processes occurring inside
aneurysms treated endovascularly, including die effects of flow alteration on genetic
expression of ceils within an aneurysm.
Mechanotransducnon is a relatively new area in vascular biology research, especially die
effect of mechanotransducfion on die molecukr mechanisms of aneurysm healing.
Endoluminal stents hkely conttibute to die treatment outcome by promoting thrombosis
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witbin the aneurysm, redirectmg blood flow within the parent vessel, forming a scaffold
for neointima formation, and by buffenng hemodynamic forces imphcated in recunences.
This work provides further evidence that stents alone are flot a reliable means to treat
aneurysms, only occasionally resulting in anearysm tbrombosis. For tins reason, an
addiflonal endosaccular thromboflc agent (most often coils) is often used to promote
thrombosis. Coils properly placed beyond the margin of die aneurysm neck do flot
modify flow in the parent vessel, and remain passive recipients of the hemodynamic
effects of pulsatile blood flow. Stents at least pardy serve as a guidance tube through die
parent vessel, decreasing blood flow into potential space outside die confines of the stent.
This reduces die dissecting force of radial-directed blood entering die aneurysm inflow
zone.
In lateral wall aneurysm models, recurrences are typïcafly characterized by a larger
recurrence at the inflow (distal lip of the ostium) compared to die outflow zone (Figure
5.4). The force of blood flow striking the fresffly-formed aneurysm thrombus at die
inflow zone may promote die formation of an endoluminal wall defect at die site of
maximal impulse.
FIGURE 5.4 Schematic ifiustrating die larger aneurysm recurrence at die distal lip
compared to die proximal aneurysm lip.
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For blood ffiat continues to enter ffie aneurysm, passing through the stent struts hkely
mcreases flow turbulence and decreases shear stress. Studies of blood flow in
atherosclerosis have shown that turbulence increases neointima formation; cellular
proliferation is stimulated, while laminar blood flow pattems exerts a suppressive effect
[64]. Neointima formation is greater in die lee of the main thmst of blood flow, sucli as
on die proximal (non-flow divide) side of a branch vessel[67j. The observed increased
neointima wiffi turbulent flow suggests that akin to atherosclerosis, the dismpted flow
charactensflcs blood enteting a stented aneurysm may initiate changes in gene expression
diat translate into biological effects including formation of more robust neointima.
The location of die stent at the junction of parent vessel and aneurysm neck, as compared
to die often more-recessed platinum coils, may have promoted neointima formation up to
and around the stent struts. The scaffolding properties of die stent may therefore serve to
help re-create a new endoluminal boundary and maximize neointima formation at die site
crucial to prevent recunences - die junction of die parent vessel and aneurysm neck.
Finally, the ability of the stent to reduce the impulse of blood entering die aneurysm by
dispersing die force over a greater surface area may have served to buffer nefanous
hemodynamic signals transmitted to buned endothelial ceils. As further discussed in the
following section, parietal or seeded circulating endothelial ceils covered by thrombus may
rely on mechanical guidance cues transmitted through die provisional mattix to form
endotheliaEzed channels through or around an intravascular thrombus. These small
channels may be a necessary precursor to aneurysm recurrences, and die ability of die
stent to disperse and partially absorb these mechanical signals may promote stable
aneurysm occlusion by limiting die success of formation of channels back to die parent
vessel from within die aneurysmal thromhus.
5.4 THE ROLE 0F THE ENDOTHELIUM
The endodielial lining is known to be associated widi residual necks and aneurysm
recunences afrer embolizaflon in animal models[93, 98]. Initially assumed to 5e a
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quiescent layer of ceils simply deffiiing the boundary of the endoluminal space, the abffity
of this dynamic cellular layer to dramatically alter disease processes is increasingly
recognized.
Removal of the endothelial layer likely influences aneurysm healing through a combination
of at least three mechanisms. First, physical removal of endodielial ceils eliminates the
tbrombolytic and and-thrombotic EC surface, exposing a large surface area of
thrombogenic collagen, which may promote a more vigorous thrombotic and healing
reaction. Classical experiments in vascular pathology have associated the extent of
endothelial denudation with subsequent neointima formation, and implicated die role of
re-endothelialization in limiting re-stenosis [204, 2051. The effects of exposing
subendothelial tissue on circulating or local factors involved in the vascular healing
response is incompletely known, but the activity of some growth factors is known to be
modifled by binding to collagen[206].
Denudation also removes the endothelial contribution to cellular signaling cascades. In
aneurysms with intact endodielium, thrombus formation within the aneurysm sac coats
the endoffielial ceils and deprives them of their blood supply. The ensuing hypoxia and
acïdosis likely triggers changes in genetic expression that may impact vascular healing
mechanisms. Although these molecular pathways remain obscure, a negative impact of
endothelial ceil signahng on durable experimental aneurysm occlusion seems biologically
plausible. The endothelium is also important in recruiting ceils of monocytic lineage,
possibly in an MCP-1 dependent fashion, and monocytes may in turn play an important
role in recanalization[207, 2081.
finally, die layer of endothelial ceils buried under die intra-aneurysmal dot may participate
in die formation of neovessels witbin die thrombus. (Recent evidence supporting die
seeding of thrombus widi circulating endodielial progenitor ceils may also place
endodielial ceils within die substance of die thrombus as well as at die thrombus/wall
interface.) In angiogenesis, isolated clusters of endothelial ceils have been shown to
burrow in multiple directions. In experimental models, spatially separate endodielial ceils
Une up along force Unes and proliferate in deflned directions in response to mechanical
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signais sensed through the extracellular matrix [60, 180]. The clusters of proliferating
endothehal ceils form contacts wiffi other burrowing endoffielial ceils and form cords,
which are the precursors to blood vessels.
Should buried endothelial ceils survive the low oxygen tension witbin the thrombus, they
may participate in the formation of two types of neovessels: those proliferatmg to supply
the neointimal ceils of the organized thrombus, or those participating in the process of
recanalization. Centdpetally-directed migration of neovessels (likely onginating from vasa
vasorum or advenfltial tissue layer) into die substance of an organizing aneurysm may
encounter and incorporate buried endoffielial ceils, restoring their blood supply. The
endothelial ceils thus form lined channels witbin die substance of the aneurysm to reach
buried neointimal ceils. For this reason, the tissues surrounding an aneurysm may be
important to aneurysm healing processes; an insufficient blood supply may lead to
insufficient organization of the aneurysmal sac. With respect to our canine model, it is
important to note that the soft tissues of die canine neck surrounding the experimental
aneurysms certainly represent a different environment compared to die cerebrospinal ftuid
of die subarachnoid space. The second type of ‘neovessel-like’ structure to winch buried
endothelial ceils may join up with are channels or crescents involved in recanalization (see
also section 5.2). Endoffielial ceils buried within die orgamzing tbrombus may be
incorporated into and contribute to the formation of recanali2ing channels. Because these
channels originate from the parent vessel and extend into die substance of die treated
aneurysm, it seems plausible diat they could enlarge and dilate secondary to contraction of
the organizing dot and die presence of appropiiate hemodynamic factors, forming a
recuirence.
Because of die implication of die role of the endothelium in aneurysm recurrence,
removal of tins ceil layer seems a desirable treatment goal. However, diere is considerable
concem about die safety of denuding aneurysms via the endovascular route. Because
aneurysm rupture ultimately occurs due to an abnormal thinning of die blood vesse1 wall,
any freatment that further removes ceil layers threatens to promote aneurysm rupture.
One potential solution to tins problem would make use of the fact diat most aneurysms
rupture at the dome; a staged approach with coil deposifion to protect die friable dome
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could be followed by a subsequent treatment, where the remainder of ffie aneurysm neck
could be denuded to promote good neointimal formation where it is rnost needed, at the
JunCtion of die parent vessel and aneurysm neck. A potenflal means to accomplish this
would be to inflate a balloon across die neck of die aneurvsm with a microcatheter inside
the aneurysm, which could release a de-endothelializing liquid into the aneurysm, foilowed
by furdier embolizanon wiffi coils and possibly a stent.
One final note regarding endothelial denudation bears mentioning. The published benefit
of endovascular coiling over surgical cippmg was demonstrated widi old-generaflon coils,
which were stiffer and more difficuit to deploy, likely resulting in at least some damage to
die endothelium. As newer generanon sofrer coils designed to decrease die risk of
aneurysm perforation are intToduced to die market, inadvertent denudadon may be
decreasing. Any treatment benefits accrwng from this inadvertent damage to the
endodielium may disappear with softer coils, further reinforcing the need for rigorous pre
clinical evaluaflon of ail new endovascular devices.
5.5 EXPERIMENTAL LIMITATIONS
The limitations of this work can be divided into general limitations of animal models of
aneurysms and diose related to the use of stents, as weil as concerns specific to die
individual projects.
5.5.1 General Limitations
As widi ail smdies using animais, costs and ethical concems limits die number of animais
used. The smail number of dogs affected oui: staflsdcs, and by using such a small n, we
may have missed a significant resuit. Odier general concems include surgical and
procedural variability, as aneurysm creation was a responsibility shared by two different
surgeons. Surgical decision-making at time of operation included how much vein to
hanrest to form die vein pouch, which in tum determined the height of the aneurysm; die
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size of the artenotomy, which dictated aneurysm neck size, aneurysm hemodynamics, and
die amount of stretch of die vem segment required to form die anastomosis. Mechamcal
manipulation of die artery beanng die aneurysm at surgery occasionally led to vasospasm,
which may have transiently affected die hemodynamics of blood entenng die aneurysm.
The endovascular procedures, aldiough primarily performed by one operator, were subject
to considerable vaiiability, in terms of contrast injection volumes and rates, variable
cadieter posinoning, and inflation pressures, wbich may have affected angiographic and
mRNA expression results. Variable posinoning of die stent struts with respect to die
aneurysm ostium may have led to vanability in die manner and degree to winch flow was
disrupted. Furthermore, die Rmited number of available stents led to die use of more
dian one size and type of stent design, winch may have vatiably affected hemodynamics
and tissue reaction. Finally, for padiological analysis die presence of die metallic stent led
to difficuffies in tissue processing, introducing ardfacts into die padiological specimens.
Notably, it made die study of die endodielium covering die luminal portion of die stent
very difficuit. Nonedieless, die uniform tubular stent handled more predictably dian
endovascular coils.
Venous pouches also certainly differ from naturally occurring aneurysms, in dieir cellular
composition but perhaps also in dieir biological reaction. The location of die
expenmental vein pouch aneurysms within die soft tissues of die canine neck differs from
diat of die subarachnoid space where most aneurysms are found; die sunounding
environment may influence die cellular and molecular response to aneurysm treatment.
Finally, because die fibrinolytic systems of dogs is more active compared to humans, die
withholding of antiplatelet agents in expenments using tins canine model may alter die
process of thrombus maturation or neointima formation within aneurysms.
5.5.2 Spedfic Limitations
5.5.2.1 Lingual LateraL Watt and Carotid Bifurcation Project
We chose die lingual lateral wafl aneurysm model because die presence of multiple pen
aneurysmal branch vessels minics most human intracranial aneurysms. The smaller
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arterial caliber and aneurysm size at the lingual position, wiffi lesser hemodynamic forces,
may be an important factor limitmg generalization of our resuits. Attempts to replicate
the resuits of stenting and endothelial denudatton of the lingual model in the bifurcation
model (with greater hemodynamics) failed, suggesting that aneurysms subjected to greater
forces may require a different or additional treamient strategy.
5.5.2.2 mRNA expression Project
The small number of dogs used per urne-point was our greatest experimental limitation.
We experienced considerable difflculty with mRNA degradation at die outset of our
expedments, leading to the use of Triaol to presewe the aneurysm tissue pnor to freezing
in liquid nitrogen. In spite of this precaution, ofren die expression of the ubiquitous
enzyme GAPDH was nonexistent, leading to die loss of one specimen. Altemaflvely,
afrer running the gel, die expected hands were found to be destroyed, with nucleic acid
fragments settling out into die bottom of die gel. Part of die difflculty widi attempting to
amplify and quantitate the geneuc expression of tissue forming within an aneurysrn using
RT-PCR is that in some cases, the aneurysm fundus would be devoid of tissue, while in
odiers it would contain variable amounts of ceils and extracellular matrix. Because RT
PCR amplifies the mRNA present and compares it to die expression of a lmown standard,
in some cases die aneurysm was an empty space, while in odiers there was found a
variable amount of thrombus formation, leading to difficulties in comparing tissue
samples. b address these problems, molecular tools appropnate to canines need to be
developed. Alternatively, die development of an adequate aneurysm model in a smaller
species, such as mouse or rat would greatly facffitate biochemical and molecular studies
and enable die use of a greater number of animals. It is worth menuoning that die PCR
data generated wiffi this mediod was only semi-quantitative; real-dme PCR would likely
yield more precise resuits. This technique also does flot permit quantitation of protein
levels.
Anodier problem related to die biochemistry project included the incidence of crushed or
migrated stents. We discovered that some dogs wore collars and leashes wbile being cared
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for by die animal technicians, and rambuncflous acfivity may have led to die collar
crushing the stents or triggering migration. This problem would flot affect humans, where
die skull would protect stents from extemal compressive forces, ahhough cmslied stents
have been reported in more accessible locations, such as die carotid bifarcaflon[209j.
5.6 FUTURE DIRECTIONS
As in many areas in medicine, more work needs to be done in the domain of public healdi
to reduce die prevalence of smoking and tobacco-related disease in our population.
Aldiough die indications for treatment of mptured aneurysms are becoming more clear,
die best treamient, if any, of unruptured intTacranial aneurysms remains a contentious
issue. The mukicenter randomized TEAM study, initiated by the clinical arm of our
laboratory, promises to shed light on die natural bistory of unruptured aneurysms, wbich
will guide clinical decision malting regarding aneurysms. More work remains to be done
to characterize the ideal stent design for die treatment of intracranial aneurysms, taking
into accourit aneurysm morphology, location, and hemodynamics, and die adjunctive
treatments being used. In our laboratory, we will persist in our search to uncover the
molecular mechanisms of aneurysm healing. In light of die major difficulues secondary to
die unavailabffity of biomolecular tools for dogs, there is considerable interest in our
laboratory in developing a mutine aneuiysm model for molecular biology work. Although
attempts dius far have led to unacceptable experimental mortality rates, we will continue
to devise new and safer ways to create experimental aneurysms in a smaller model. One
future project diat promises to yield insight into die role of die endodiehal lining in
aneurysm recurrences would explore die differences in mRNA expression between
denuded and non-denuded aneurysms.
Finally, a safe method to remove die endodielial lining through an endovascular approach
remains to be found.
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5.7 CONCLUSIONS
The process of aneurysm healing following endovascular therapy remains a complex,
incompletely understood process. Nonetheless, several conclusions emerge from this
body of work: first, stents alone are usually insufficient to treat aneurysms, but they can
significantly improve angiographic and pathologic resuits. Second, the beneficial resuk of
stenting can be augmented by combining it with endothelial denudation, which is
sufficient for aneurysm occlusion in the low-hemodynamic lingual modeL Third, the use
of stents is not without risk to perforatmg vessels originating from under the stented
segment.
Trends in mRNA expression changes of ceils of the aneurysm wall in response to stenting
supported a role for flow modification in the process of neointima formation and
thrombus organization. We also found a trend to support the formation of
endothelialized channels within the aneurysm thrombus, implying that recanakzation
affects endovascularly treated aneurysms. Unfortunately, the mRNA expression
differences due to stenting did not reach statistical significance.
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